World Health Summit Berlin, Germany October 27–29, 2019 Venue

SCIENCE · INNOVATION · POLICIES

WORLD HEALTH SUMMIT BERLIN, GERMANY OCTOBER 27–29, 2019 VENUE

Kosmos WiFi Karl-Marx-Allee 131 a Network: WorldHealthSummit 10243 Berlin, Germany Password: #WHS2019

SAAL 10 ASIA

SAAL 7 ELIZABETH BLACKWELL

Speaker Center M8 SAAL 1 SAAL 6 Foyer Lounge RUDOLF VIRCHOW EUROPE Press Area Karl-Marx-Allee OUTDOOR ROBERT KOCH Meeting Point SAAL 5 OCEANIA

SAAL 2 SAAL 4 AMERICA AFRICA WORLD HEALTH SUMMIT BERLIN, GERMANY OCTOBER 27–29, 2019 SUNDAY | OCTOBER 27, 2019

SAAL 1 SAAL 6 SAAL 10 SAAL 2 SAAL 4 SAAL 5 RUDOLF VIRCHOW EUROPE ASIA AMERICA AFRICA OCEANIA

PD 01 | Page 22 PD 02 | Page 24 PD 03 | Page 26 WS 01 | Page 28 WS 02 | Page 30 11:00 – Gender Equality Polio Eradication Antimicrobial Nutrition and European Initiatives 12:30 within the Global Alliance Resistance Non-Communicable, for Health Research Health Workforce The Graduate Institute World Health Metabolic Diseases and Development Women in Global Health Geneva – Global Health Organization (WHO) in Sub-Saharan Africa BioMed Alliance Center German Institute Charité – Universitäts- of Human Nutrition medizin Berlin Potsdam-Rehbrücke Alliance (DIfE) Leibniz Institute for Prevention Research and Epidemiology (BIPS) Bremen 12:30 – 14:00 Lunch Break PD 04 | Page 32 PD 05 | Page 34 PD 06 | Page 36 WS 03 | Page 38 WS 04 | Page 40 14:00 – The Role of AI in Securing Political Protecting the Mental Evolutionary Medicine Traditional Medical 15:30 Healthcare Innovation Leadership for Global Health of Refugees University of Zurich Practices and Global EIT Health (European Health to Accelerate and Migrants Health Institute for Innovation the Elimination Istanbul University Kiel University and Technology) of Communicable Alliance Alliance Diseases Sapienza University UNITE Tehran University of Medical Sciences (TUMS) University of Geneva 15:30 – 16:00 Coffee Break PD 07 | Page 42 PD 08 | Page 44 PD 09 | Page 46 WS 05 | Page 48 WS 06 | Page 50 16:00 – Sustainability of Accelerating Innova- Respect and Dialogue Falsified and Sub- How Microbiomedical 17:30 Healthcare Systems tion for Impact InterAcademy Standard Medicines Research is Changing Sanofi German Health Alliance Partnership (IAP) Association of Research- Medicine (GHA) Alliance based Pharmaceutical Max Delbrück Center UNAIDS Tehran University of Companies (vfa) for Molecular Medicine Medical Sciences (TUMS) (MDC)

KEY 01 | Page 52 18:00 – Opening Ceremony 19:30 Alliance World Health Summit

19:30 – Welcome Reception 22:30

Keynote Panel Discussion Workshop MONDAY | OCTOBER 28, 2019

SAAL 1 SAAL 6 SAAL 10 SAAL 2 SAAL 4 SAAL 5 RUDOLF VIRCHOW EUROPE ASIA AMERICA AFRICA OCEANIA

PD 10 | Page 56 PD 11 | Page 58 PD 12 | Page 60 WS 07 | Page 62 WS 08 | Page 64 9:00 – Universal Health From Words to Action: Bridging R&D and Neglected Tropical Climate Change 10:30 Coverage Transforming Mental Sustainable Access Diseases and Inclusion and Public Health Global Solutions Initiative Health Globally to Antibiotics under the Umbrella Charité – Universitäts- of Universal Health Alliance Harvard Medical School Global Antibiotic medizin Berlin Research & Development Coverage The Graduate Institute Alliance Partnership (GARDP) Geneva – Global Health Association of Research- Potsdam Institute Center based Pharmaceutical for Climate Impact Companies (vfa) UHC2030 Research Eberhard-Karls- Stiftung Mercator University Tuebingen German Network against Neglected Tropical Diseases (DNTDs) German Society for Tropical Medicine and International Health (DTG) Universitätsklinikum Tuebingen 10:30 – 11:00 Coffee Break KEY 02 | Page 66 PD 13 | Page 68 WS 09 | Page 70 WS 10 | Page 72 11:00 – Transforming A Comprehensive How to Ensure The SDG3 Global 12:30 Human Capital Approach to Global Sustainable Elimination Action Plan for Health Alliance Health and Security of NTDs and Wellbeing National University German Federal Drugs for Neglected German Federal Ministry of Singapore (NUS) Foreign Office Diseases initiative (DNDi) of Education and German Federal Sanofi Research (BMBF) Ministry of Defense Lancet Commission on One Health 12:30 – 14:00 Lunch Break PD 13a | Page 74 WS 10a | Page 76 12:45 – Entrepreneurs in Global 12:30 – The One Health 13:45 Health Presentation 14:00 Concept KEY 03 | Page 78 PD 14 | Page 80 WS 11 | Page 82 WS 12 | Page 84 14:00 – Focus Africa Artifical Intelligence How can Health Prioritizing Infectious 15:30 Alliance for Health Insurance Schemes Help Diseases for Makerere University Berlin Institute to Develop Sustainable Surveillance in Africa of Health (BIH) Health Systems in Helmholtz Centre for Fraunhofer Heinrich- the BRICS countries? Infection Research (HZI) Hertz-Institut Manipal Academy of Higher Education 15:30 – 16:00 Coffee Break PD 15 | Page 86 PD 16 | Page 88 PD 17 | Page 90 WS 13 | Page 92 WS 14 | Page 94 16:00 – Access to Medicines Smart Investment The Life-Saving Power Capacity Building in Reforming Health 18:30 International Federation in Equitable Health of Mobile Technology Health Research in Systems of Pharmaceutical Systems Heidelberg Institute of Low-Resource Settings Hertie School Manufacturers & ATscale – Global Global Health (HIGH) European & Developing Robert Bosch Stiftung Associations (IFPMA) Partnership for Assistive Charité Global Health Countries Clinical Trials Technology Partnership (EDCTP) Ottobock SE & Co. KgaA German Federal Ministry The George Washington of Education and University, Milken Institute Research (BMBF) School of Public Health Institut Pasteur

18:00 – World Health Summit Night | Page 96 23:00 TUESDAY | OCTOBER 29, 2019

SAAL 1 SAAL 6 SAAL 10 SAAL 2 SAAL 4 SAAL 5 RUDOLF VIRCHOW EUROPE ASIA AMERICA AFRICA OCEANIA

PD 18 | Page 98 PD 19 | Page 100 PD 20 | Page 102 WS 15 | Page 104 WS 16 | Page 106 9:00 – The Commercial Climate Change Access to Quality How Can We Create Co-Creation and 10:30 Determinants of Health and Health Health Care for Women Sustainable Value for Co-Ownership of the Tobacco Free Portfolios German National in Low Resource Patients and Society UHC and SDG Agendas Academy of Sciences Settings European University Drugs for Neglected Leopoldina e.V. Charité – Universitäts- Hospital Alliance Diseases initiative (DNDi) InterAcademy medizin Berlin Partnership (IAP) Alliance

10:30 – 11:00 Coffee Break PD 21 | Page 108 PD 22 | Page 110 PD 23 | Page 112 WS 17 | Page 114 WS 18 | Page 116 11:00 – Tackling Unmet Medical Global Public Health Health Data as a Access to Sustainable The SDG3 Global 12:30 Needs of Vulnerable and Security Global Public Good NCD Treatment and Care Action Plan for Health Neglected Populations Centre on Global Health Fondation Botnar Boehringer Ingelheim and Wellbeing Charité – Universitäts- Security, Chatham House The Lancet & Financial Pharma GmbH & Co. KG Wellcome Trust medizin Berlin International Association Times Commission: The Defeat-NCD European & Developing of National Public Health Governing Health Partnership Countries Clinical Trials Institutes (IANPHI) Futures 2030: Growing Partnership (EDCTP) Robert Koch Institute Up in a Digital World Alliance Max Planck Institute for Infection Biology 12:30 – 14:00 Lunch Break WS 19 | Page 118 WS 20 | Page 120 12:30 – Better Leadership: New Voices 14:00 Improved Health in Global Health ESMT European School Global Young Academy of Management and World Health Summit / Technology GmbH WHS Foundation GmbH InterAcademy Partnership (IAP)

KEY 04 | Page 122 PD 24 | Page 124 14:00 – Health is a Digital Health 15:30 Political Choice Global He@lth 2030 German Federal Ministry Innovation Task Force of Health (BMG) World Health Organization (WHO) 15:30 – 16:00 Coffee Break KEY 05 | Page 126 16:00 – The SDG3 Global 17:30 Action Plan for Health and Wellbeing German Federal Ministry of Health (BMG) World Health Organization (WHO)

Keynote Panel Discussion Workshop TABLE OF CONTENTS 5

Welcome Messages 6 • High Patrons of the World Health Summit 6 • World Health Summit Presidents 11 • Charité – Universitätsmedizin Berlin 12

About the World Health Summit 14

About the M8 Alliance 15

Central Topics 2019 16

Initiatives 18

Program 21 • Program Sunday, October 27, 2019 21 • Opening Ceremony and Reception 54 • Program Monday, October 28, 2019 55 • World Health Summit Night 96 • Program Tuesday, October 29, 2019 97

General Information 129 • Useful Information 130 • City of Berlin 134 • World Health Summit 136 • M8 Alliance 140 • Speaker Index 143 • Supporting Institutions 146 • Partners 148 • World Health Summit Office 153 • Imprint 156 6 WELCOME MESSAGE HIGH PATRONS OF THE WORLD HEALTH SUMMIT

2018 to guide the elaboration reasons to hope that Ebola can of a Global Action Plan to imple- be curbed effectively. In order ment the 2030 Agenda’s health to achieve this in the case of goals. Twelve international other dangerous infections, too, organisations were involved in such as lassa fever, Germany drafting this Action Plan, which is supporting the Coalition for WHO presented during UN Week. Epidemic Preparedness Inno The outcome is very gratifying. vations (CEPI), which will invest The plan provides us with a solid up to a billion dollars in devel Health and well-being is a key basis for improving support oping new vaccines. goal of the 2030 Agenda for services in specific countries Sustainable Development, to and making achievements more In view of the possible dangers which the international commu- measurable through intermedi- that pandemics pose to human nity has pledged its support. ate goals, thus enabling rapid life, but also to entire regions’ At the UN Sustainable Develop- adjustments where necessary. economies, security and devel- ment Summit in late September, I am confident that with the help opment, it is and will remain the Heads of State and Govern- of this Action Plan, it will be important that we support the ment spelt out that the Agenda possible to further improve the countries of the Global South is not being implemented fast coordination of the countless in developing resilient education, enough. In order to achieve activities in the health sector and research and health systems. the Sustainable Development thus use funds more efficiently. The Research Network for Health Goals by around 2030, we must Innovations in sub Saharan Africa, significantly strengthen our The current outbreak of Ebola which is funded by the Federal endeavours worldwide. Above in the Democratic Republic of Government, is one example of all, this requires developing a the Congo once again highlights how this can be achieved in the common understanding on how the importance and urgency field of health research. Our to proceed and pooling our of coordinated action. However, German-African partnerships aim strengths, including on global we are in a better position than to identify solutions to current health issues. during the epidemic of 2014 health problems that can be put 2015 in West Africa. Experimen- into practice on the ground. To this end, Norwegian Prime tal vaccines and treatments are Minister Erna Solberg, Ghanaian being used successfully. Despite Diseases and epidemics do not President Nana Addo Akufo- great concern about the current stop at national borders. Re- Addo and I asked WHO in April outbreak, there are thus good sponsibility for healthcare thus WELCOME MESSAGE 7 HIGH PATRONS OF THE WORLD HEALTH SUMMIT

does not end there either. Summit in Biarritz on August 26, The World Health Summit plays we reiterated that universal a key role in living up to this access to social protection and responsibility. As patron of affordable quality health ser- the Summit, I am profoundly vices with primary health care grateful to all those who play are crucial. We called for further a part in its success, as the investments to strengthen health event focuses on new and systems and eliminate the three better prospects for the lives most lethal infectious diseases— of people all over the world. I am very pleased to offer my aids, tuberculosis and malaria. On that note, I hope your patronage to the World Health We adopted a Sahel Partner- exchange of thoughts and Summit, as I did on two previous ship Action Plan to enhance experiences at the Summit will occasions along with the German development in the Sahel region. prove both interesting and Chancellor and the President This plan has a specific focus productive. of the European Commission. on gender equality and women’s This 2019 Summit provides once empowerment and aims at more a stimulating opportunity reaching the most affected for dialogue, exchange, and communities. learning. It comes at a challeng- Angela Merkel ing and inspiring time for global This year, the United Nations Chancellor of the health, calling for reinforced General Assembly bolstered the Federal Republic of Germany multilateral action, an approach achievement of the Universal strongly supported by both Health Coverage. France has Germany and France. always been a strong advocate of universal health coverage During the last months, France as a fundamental right: access played an active part in this re- to health and well-being must spect as Chair of the G7 focusing be guaranteed, regardless of on the fight against inequalities. one’s wealth. France implement- The fourth G7 Health ministerial ed universal health coverage meeting which took place in decades ago and, ever since, Paris in May brought forward this has proven to be a funda- access to primary health care as mental basis for our national a shared priority. At the G7 cohesion and prosperity. We 8 WELCOME MESSAGE HIGH PATRONS OF THE WORLD HEALTH SUMMIT

must remain committed to malaria, AIDS and new drug- this global challenge. We have resistant forms of tuberculosis. to make health systems more resilient in order to provide This has been a truly collective equal access to care and to effort, with civil society, private make high quality medicines sector stakeholders, founda- available at a fair price. We have tions, activists and communities, to ensure that we take on board pushing for more commitments, vulnerable populations, and offering solutions and taking achieve gender equality. action, alongside donor and Europeans share a number of recipient countries. SDGs for common goods with the rest of A few weeks ago, France hosted health are not concerns for the world. We have the desire the Global Fund to Fight AIDS, States alone. They are common to be safeguarded, to feel secure Tuberculosis and Malaria’s Sixth goals and the World Health and protected. We have similar Replenishment Conference in Summit is an opportunity to political aspirations, like democ- Lyon. The international commu- share this energy for action. racy and freedom. But one good nity gathered to step up the Let us be actively optimistic for is the premise of all: health. It fight against these three pan- a healthier future. is one we protected and cher- demics, putting us back on track ished, so that today we live and to achieving the Sustainable I would like to thank the organ- age healthily, and more people Development Goal on health izers for the wise choice of topics have access to healthcare than and well-being for all. Working for the Summit and especially ever before. closely with partners, at inter the focus on Africa. I wish national and local level, the all participants constructive But we cannot afford to lapse Fund has achieved great results, discussions. into complacency, as the mere opening up access to new pre- topic of vaccination reminds us. vention, protection and screen- Each year, vaccination saves ing methods, as well as medica- up to three million human lives tion and healthcare, and saving around the world. Some diseas- 32 million lives. Hundreds of es like smallpox, once consid- millions of people are now living ered a death sentence, belong better lives. With joined forces, to the past. Yet, the recent surge we helped the Global Fund to Emmanuel Macron in measles and other diseases continue its mission to eradicate President of the Republic of France close to eradication is a worry- WELCOME MESSAGE 9 HIGH PATRONS OF THE WORLD HEALTH SUMMIT

ing sign that we are losing At the recent meeting of the issue, including most recently ground. Without adequate G7 in Biarritz, the EU announced with legislation addressing the immunisation coverage, a record €550 million contribu- public and animal health risks we are putting people’s lives tion to the Global Fund to fight caused by resistance to anti at risk. AIDS, malaria and tuberculosis. biotics in the EU. For many African countries, the Our response should be global, Global Fund is the single most We, as institutions and politi- and Europe has already taken important external financer of cians, call for growth, jobs and a step forward. At the World the health sector and the EU opportunities. But we shall be Vaccination Summit it hosted and its Member States have been judged by how we treat our less than a month ago, the the main contributors since its people. Because it is the health Commission presented priority creation. When our common of all our citizens that is the true measures to address increasing good is at risk, we invest in build- mark of our progress as a society. disinformation about vaccina- ing quality health care systems tion, and tackle the lack of in more than 80 countries It has been an honour during access, vaccine shortages and around the world; we deploy our my mandate as President of the disinvestment, which are all European Medical Corps with European Commission to offer causing vaccination to stagnate on-call medical assistance and my patronage to the World across the world. public health expertise when Health Summit, a distinguished disaster strikes; and we broaden forum that acts for the greater As we strive to hold on to the and deepen our work with the good. I wish you all the best progress we have already made, World Health Organization. for another inspiring summit it is paramount that we continue this year. investing in the vital research There are few clearer examples that will lead to medical break- today of a truly global threat throughs and better health. than antimicrobial resistance. From EU-funded research on The World Bank estimates Jean-Claude Juncker breast cancer treatment to severe economic damage as a President of the EU-funded researchers making result, the likes of which we have European Commission X-rays safer for patients, it not seen since the 2008 finan- is when we pool national and cial crisis. Worse, by 2050 it European resources that we could cause 10 million deaths can deliver results. This is no worldwide. The European Union zero-sum trade-off. has long been engaged on this 10 WELCOME MESSAGE HIGH PATRONS OF THE WORLD HEALTH SUMMIT

people will lack access to essen- enhance our collaboration and tial health services by 2030. turbocharge our impact. The And every year, about 930 million initial commitment towards the people are exposed to catas Global Action Plan was launched trophic health spending. at the World Health Summit in 2018 and the plan itself at the Reversing these trends will UN General Assembly in Sep- require a relentless focus on tember 2019. people-centred primary health At the United Nations General care, with an emphasis on Together, we have committed Assembly this year, world promoting health and prevent- to engage with countries to leaders endorsed the political ing disease. It will also require identify priorities, to accelerate declaration on universal health robust partnership. There are progress through joint action in coverage (UHC), the most now many more international seven programmatic areas, to comprehensive international actors in global health than align our operational and finan- health commitment in history. there were when the World cial strategies and policies, and Health Organization was found- to account for the results we Building on the Sustainable ed in 1948. This creates com- deliver. Development Goals and the plexities and challenges, but it Declaration of Astana on pri- also represents a unique oppor- The 12 organizations that are mary health care, the political tunity to leverage our collective signatories to the Action Plan are declaration on UHC represents strength to accelerate progress deeply aware that we cannot unprecedented commitment towards the health-related achieve its ambitions by our- from all 193 UN Member States SDG targets. selves. We need countries, com- to a world in which no one munities and civil society, the misses out on essential health At the invitation of Chancellor private sector, academia, and services simply because they Angela Merkel of Germany, other stakeholders and develop- cannot access or afford them. Prime Minister Erna Solberg of ment partners to accelerate pro- Germany and President Nana gress and increase the impact of Realising this vision, of course, Akufo-Addo of Ghana, 12 multi- our joint work through the next will be no easy task. The latest lateral health agencies have “decade of delivery” on the SDGs. edition of the Global Monitoring come together to launch the Report on UHC shows that on Global Action Plan for Healthy Now our focus must be on work- current trends, up to 5 billion Lives and Well-Being for All, to ing together to implement the WELCOME MESSAGE 11 HIGH PATRONS OF THE WORLD HEALTH SUMMIT

plan in countries. Accordingly, I am proud to be a founding the 12 agencies are focusing on member of the World Health identifying what countries want Summit steering committee, and how the agencies can work and am delighted to see the way even more closely together it has grown in size and stature to support countries, leading since 2009. I am equally proud, to accelerated impact on the together with Chancellor Merkel, health-related SDGs. President Macron and President Juncker, to be its patron. WHO also recognizes that we need to change to ensure we deliver the results the world expects of us. As part of our current transformation project, we have developed a new Tedros Adhanom Ghebreyesus strategy, new operating model, Director-General of the new business processes, new World Health Organization (WHO) culture and a new approach to partnership.

WHO is delighted to strengthen its collaboration with the World Health Summit, which is now one of the foremost gatherings in global health. It brings together heads of state, ministers from different sectors, Nobel prize winners, leading CEOs, academics, foundations and civil society. It recognizes the voices of youth and women and aims to increase the diversity that successful global health action requires. 1212 WELCOME MESSAGE WORLD HEALTH SUMMIT PRESIDENTS

healthcare workers, businesses, and civil society must combine their expertise and coordinate resources. Together, we can expedite progress. We can ensure more people benefit from new and existing therapies, improved healthcare systems, and insights about social and environmental determinants of health. Ali Jafarian Detlev Ganten Health is a human right, and is critical not only for SDG3, but central to all the Sustainable Development Goals. We welcome the prominent position that health topics have assumed on the the G7 and G20 agendas, and we WELCOME TO THE are glad to see the World Health Organization receiving more support and other key organizations playing an WORLD HEALTH SUMMIT 2019 increasingly coordinated role in supporting the United Nations in achieving these goals.

When it comes to global health, each of us must act, From ministers and international organizations to local but we can do very little alone. From climate change to actors and students, we are all here to take responsibility noncommunicable diseases, basic research to universal for shaping the future of the global health agenda. health coverage, some of the biggest health challenges On behalf of the World Health Summit and our wonder of our time affect people everywhere and require ful academic backbone, the M8 Alliance, we wish collaboration across borders. At the World Health everyone fruitful discussions, meaningful insights, and Summit, voices from all over the world come together strengthened collaborations for global health at the to do just that. World Health Summit 2019 in Berlin.

Improving health is something we can all agree on, and the World Health Summit is a platform where everyone pursing this goal can exchange ideas freely. After a successful Regional Meeting in Iran, we look forward to carrying this momentum and spirit of inter- Ali Jafarian Detlev Ganten national cooperation forward. International President 2019 Founding President It’s not just geographic borders we need to reach World Health Summit World Health Summit across. Every sector of society must be involved in Former Chancellor Tehran creating a healthier future. Scientists, policymakers, University of Medical Sciences WELCOME MESSAGE 13 CHARITÉ – UNIVERSITÄTSMEDIZIN BERLIN

Charité is proud to be part of the M8 Alliance, which serves as a foundation of academic excellence for the World Health Summit and provides a platform for year-round collaboration. Local partnerships too can be powerful tools for global health. This year, the Berlin University Alliance was awarded Germany’s Heyo Kroemer Axel Radlach Pries competitive “excellence” designation. Bringing together four Berlin universities, the alliance was created to overcome institutional and disciplinary boundaries and take on global challenges, including global health.

DEAR WORLD HEALTH SUMMIT Charité has a responsibility to ensure world-class treatment through cutting-edge research, innovative thera- PARTICIPANTS, pies, and effective collaborations. The World Health Summit is not just an annual event—it is a forum that brings actors together from all over the world, making We are delighted to welcome excellent minds from new and powerful partnerships like these possible. around the world to Berlin for the World Health Summit. One of Europe’s largest university hospitals, Charité – On behalf of Charité, it is with great pleasure that Universitätsmedizin Berlin is dedicated to forward- we welcome you to the World Health Summit 2019. looking science, quality education, and innovation in Enjoy the city of Berlin, productive discussions among healthcare. Since it was founded at Charité in 2009, colleagues from all over the world, diverse contribu- the World Health Summit has been a shining example tions, and new collaborations towards our noble goal: of this ethos. Strengthening partnerships and working improving global health. together—among institutions, across sectors, and across borders—is key to maximizing the impact of innovations in medicine and science.

As Berlin continues to grow as a global health hub, Charité can and must take on a pivotal role. The dedicated center Charité Global Health is part of that effort, Heyo Kroemer Axel Radlach Pries expanding Charité’s global health portfolio and foster- Chief Executive Officer Dean ing increased collaborations with national and inter Charité – Universitätsmedizin Charité – Universitätsmedizin national stakeholders. Berlin Berlin 14 ABOUT THE WORLD HEALTH SUMMIT

SCIENCE – INNOVATION – POLICIES

Goals

The World Health Summit is one of the world’s leading The summit’s mission is to improve health worldwide by: strategic forums for global health. Held annually in Berlin, • Bringing together all stakeholders it brings together leaders from politics, science and • Facilitating constructive exchange in an environment medicine, the private sector, and civil society to set the of academic freedom agenda for a healthier future. 300 speakers and 2,500 • Finding answers to major health challenges participants from 100 countries take part, including: • Making global recommendations and setting health • Leading scientists and medical professionals agendas • Ministers and civil servants The World Health Summit was founded in 2009, on the • High-ranking officials at international organizations occasion of the 300th anniversary of Charité. • CEOs from industry and civil society • Young professionals and students www.worldhealthsummit.org ABOUT THE M8 ALLIANCE 15

The M8 Alliance is the academic foundation of the decision-makers to develop science-based solutions World Health Summit. A unique network of 25 leading to health challenges worldwide. international academic health centers, universities, and In addition to the annual World Health Summit in research institutions from 18 countries, it includes the October, the M8 Alliance organizes a Regional Meeting InterAcademy partnership, which represents all national each spring and various expert meetings in different academies of medicine and science. parts of the world. The World Health Summit Regional All M8 Alliance members are committed to improving Meeting 2020 will take place April 27–28 in Kampala, global health and working with political and economic Uganda.

Tehran University of Medical Sciences

Tehran University of Medical Sciences (TUMS) is accredited with premier status by the Accreditation Service for International Colleges (ASIC). ASIC is recognized by the United Kingdom Department for Education and Skills (DfES), the United Kingdom Department for Universities, Innovation and Skills (DUIS), the United Kingdom Border and Immigration Agency (Home Oﬃce), the United Kingdom Oﬃce for Standards in Education (Ofsted). ASIC is a member of Council for Higher Education Accreditation (CHEA). 16 CENTRAL TOPICS 2019

Climate Change and Health Universal Health Coverage: Climate change poses an unquestionable threat to Expanding Rights and Access human health, affecting everyone on the planet and SDG 3.8 envisions that by 2030, all people will be able children in particular. There is an urgent need to trans- use health services of sufficient quality without facing late existing evidence into policy actions and to pro- financial hardship. Despite strong international support duce new research to fill gaps in the knowledge base. for universal health coverage (UHC), country-level financ- This requires a One Health approach, considering ing and implementation remains challenging. Multi- climate change in all areas of policy development, and sectoral approaches are key to generating political will ensuring that health systems are prepared to face for investment in UHC and driving appropriate reforms. the challenges rising temperatures bring. Stronger accountability and advocacy are key to accel erating progress towards universal health coverage. Transforming Human Capital: Investing in Health and Education Health is a Political Choice: The UN high-level political declaration on UHC, adopted The Future of Health Policy in the G7/G20 in September 2019, sets out a clear agenda on the attain- and other Political Venues ment of SDG3. One of the major challenges identified Healthcare has developed into a key national and in the declaration is how to accelerate investments in international policy issue. The 2019 G20 in Osaka, Japan the health workforce to overcome the global shortages includes a meeting of health ministers on topics like predicted by 2030, especially in countries with the health security and antimicrobial resistance, as well weakest PHC systems and the furthest from UHC. as a joint meeting of finance and health ministers. The This requires building the necessary foundations for health governance issues inherent in the Sustainable PHC: investments in core infrastructure, both health Development Goals have underlined how increasing facilities and preservice education institutions, and in financial and political commitments are central to health worker employment, retention and productivity. solving global health challenges. The G7 will focus on There is an emerging opportunity to link investments issues of inequality, including access to health. Health in education, skills and jobs in the health sector with also featured strongly at the 2019 UNGA and is part the broader work of human capital and social spending, of the BRICS deliberations, and there is an opportunity engaging the international financing institutions and to give health a higher profile in upcoming EU presi all relevant partners as necessary. dencies. These complementary agendas can support the SDG-approach to address current and future social, economic, and environmental challenges. 17

SDG3: Digital Health: The Global Action Plan for Healthy Lives Shaping Society and the Modern Economy and Well-Being for All A growing, ageing global population will have a pro- The success of the SDGs will be measured by their found impact across the world. Health spending is impact on the prosperity and well-being of people and predicted to rise to $9.3 trillion by 2018. New techno- the planet, particularly the extent to which they “leave logical developments are responding and increasingly no one behind.” Initiatives such as the Global Action blurring the boundaries between the physical, biologi- Plan for Healthy Lives and Well-Being for All endeavor cal, and digital worlds. Technology aims to personalize to build a foundation of greater cohesion among global medicine and tailor treatments to individual patients health actors to support countries in their achievement based on their genetic makeup. The digital revolution of the SDGs. The action plan was launched at the World has the potential improve health and empower patients, Health Summit 2018. The World Health Summit 2019 but it could also increase health inequities and lead will include a report on its progress and the implemen- to new ethical challenges. tation challenges at hand.

Focus Africa: Building Capacities and Strong Institutions United Nations Member States have a shared commitment and a common interest in achieving the SDGs by 2030. This will require significant investment, innovation, and partnerships in Africa. Integrated approaches to health, development and security, consensus building, information sharing, and knowledge exchange will all be key. The African Union has made health one of its priorities, and there is increasing political commitment to investing in health in a number of African countries. 18 INITIATIVES

ENTREPRENEURS NEW VOICES IN GLOBAL HEALTH IN GLOBAL HEALTH

MONDAY, OCTOBER 28 TUESDAY, OCTOBER 29 12:45 – 13:45 12:30 – 14:00 SAAL 6 | EUROPE SAAL 5 | OCEANIA

A cooperation between the World Health Summit The initiative New Voices in Global Health promotes and the Charité BIH Entrepreneurship Summit, the active participation of talented young researchers Entrepreneurs in Global Health brings local and at the World Health Summit. Selected by the Global international startups to the global health stage. Young Academy, early-career scientists will present See page 74 for session details. their work at the World Health Summit. See page 120 for session details.

In partnership with: In partnership with: 19 20 PROGRAM

SUNDAY, OCTOBER 27 22 SUNDAY, OCTOBER 27

PANEL DISCUSSION

PD 01 GENDER EQUALITY WITHIN THE

SAAL 6 | EUROPE GLOBAL HEALTH WORKFORCE 11:00 – 12:30 Addressing Gender Equity to Strengthen Health for All

HOST

Women in Global Health

The health sector is a major employer of ing with opportunities to address the women globally. But although women weaknesses in health systems identified comprise around 70% of the global health in the WHO report “Global Health: workforce they are largely clustered into Delivered by Women, Led by Men.” lower status, lower paid sectors and jobs, with men holding the majority of senior The workshop will start with a plenary roles. A large percentage of female health scene setting presentation by the WHO workers in low and middle-income coun- Goodwill Ambassador for the Health tries particularly, work on insecure terms Workforce. This will be followed by a and conditions, without a supportive legal panel discussion answering the following and social protection framework. Against questions: the background of a global shortage of • How strong are political commitments 18 million health workers needed to reach to address gender and equity in the universal health coverage (UHC), address- health workforce? ing gender inequality in the health work- • What will it take to get gender trans- force will enable better use of talent and formative policy change in the health deployment of health workers, reduce workforce? attrition and generally strengthen health systems. Following the panel, the audience will ask Significant political discussions are taking questions for discussion by the panel on place in 2019 on the global health work- how to address gender inequity within force at the September UN High Level the health system, focusing on leveraging Meeting on Universal Health Coverage, political commitments, practical solutions June G20 Meeting and August G7 Meet- and actions. PROGRAM 23

CHAIRS

Hélène Boisjoly Roopa Dhatt Université de Montréal | Women in Global Health | Dean of Medicine | Executive Director | Canada United States of America Epsy Caline

Campbell Barr Mattar PROGRAM, SUN 27

SPEAKERS

Roopa Christina Dhatt Schrade

Mwenya Christiane Kasonde Wiskow 24 SUNDAY, OCTOBER 27

PANEL DISCUSSION

PD 02 POLIO ERADICATION Lessons for Global Health SAAL 10 | ASIA 11:00 – 12:30

HOSTS

M8 Alliance

The Graduate Institute Geneva – Global Health Center

Beginning in 1988, the global effort to The Global Health Centre (GHC) at the eradicate polio is the largest, longest and Graduate Institute, Geneva, has under- most expensive public health program taken a two-year study of the global polio in history. The current wind-down and eradication effort with a focus on political eventual closure of the eradication effort and governance dimensions and the has programmatic, financial and human roles of European actors. This session impacts, particularly for the World Health will present the results of the GHC study; Organization (WHO) and other countries provide the opportunity to reflect and where major ‘polio assets’, such as labora- debate on the lessons drawn; explore tories, skilled human resources, manage- how these lessons can be best used for rial and technical systems, have been the benefit of national health systems established. and global health; and assess the wider implications for health governance. These assets have massive potential for supporting both the development and strengthening of national health systems. However, with polio eradication not yet achieved and diverging opinions con cerning the timing and specific details of polio transition planning, a number of challenges remain to be addressed. PROGRAM 25

CHAIR

Stephen Matlin The Graduate Institute Geneva | Global Health Center | Senior Fellow | Switzerland

SPEAKERS Judith Bernhard Diment Schwartländer PROGRAM, SUN 27 Judith Diment Bernhard Schwartländer Rotary International | Polio Eradication World Health Organization (WHO) | Advocacy Task Force | Member Chef de Cabinet | International Polio Plus Committee | Switzerland United Kingdom Stephen Sosler Ilona Kickbusch Gavi, The Vaccine Alliance | Technical

The Graduate Institute of Advisor, Vaccine Implementation | Ilona Stephen International and Development Studies | Switzerland Kickbusch Sosler Global Health Center | Chair of the Darren Welch International Advisory Board | Department for International Switzerland Development | Director of Policy | United Kingdom

Stephen Matlin 26 SUNDAY, OCTOBER 27

PANEL DISCUSSION

PD 03 ANTIMICROBIAL RESISTANCE

SAAL 2 | AMERICA 11:00 – 12:30

HOST

World Health Organization (WHO)

The objective of this session is to review It will present and discuss the progress made internationally in • the new international governance combatting antimicrobial resistance for AMR after the finalization of the (AMR) and identify remaining challenges. IACG report, The session will review the state-of-play • how to reinforce the one-health of combatting AMR four years after approach and effectively environmental the adoption of the Global Action Plan aspects on AMR and following the report of • new initiatives in fostering the develop- the Interagency Coordination Group on ment of new antibacterial treatments Antimicrobial Resistance (IACG). and diagnostics PROGRAM 27

CHAIR

Peter Beyer World Health Organization (WHO) | Senior Advisor | Switzerland

Felicitas Riedl 28 SUNDAY, OCTOBER 27

WORKSHOP

WS 01 NUTRITION AND NON-COMMUNICABLE,

SAAL 4 | AFRICA METABOLIC DISEASES 11:00 – 12:30 IN SUB-SAHARAN AFRICA

HOSTS

German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE)

Leibniz Institute for Prevention Research and Epidemiology (BIPS) Bremen

Overnutrition and obesity are strongly based products play a role. Cardio-meta- increasing in low- and middle-income bolic diseases reduce life quality and countries (LMICs), while undernutrition increase mortality posing heavy burdens and infectious diseases continue to prevail on the national health care systems. in these regions. This development trans- Therefore, primary prevention of obesity lates into the so-called double burden of and its associated cardio-metabolic malnutrition, fueling the worrying emer- conditions considering cultural peculiari- gence of non-communicable diseases ties is essential. (NCDs) in LMICs. More specifically, cardio-metabolic diseases, including type 2 Due to the competing challenges of diabetes, hypertension, and cardio-vas under- and overnutrition, only few coun- cular conditions are on the rise in LMICs. tries in Sub-Saharan Africa have already Rapid economic growth, urbanization and implemented their own prevention pro- associated lifestyle changes are among grams. By using examples from Ghana the major causes for this development. and Zanzibar, the panel discussion will address how changes in eating behavior Particularly, the nutrition transition from and lifestyle due to external economic plant-based, fiber-rich and low-fat diets and ecologic pressure challenge respec- towards manufactured foods with high tive national health care systems. contents of simple sugars and animal- PROGRAM 29

CHAIR

Wolfgang Ahrens Leibniz Institute for Prevention Research and Epidemiology (BIPS) Bremen | Deputy Scientific Director | Germany

Wolfgang Mansura M.

Ahrens Kassim PROGRAM, SUN 27 SPEAKERS

Ina Danquah Ronald Miah German Institute of Human Nutrition Health Services Asante Akim North Potsdam-Rehbrücke (DIfE) | District | District Director | Germany Ghana

Antje Hebestreit Kremlin Wickramasinghe Leibniz Institute for Prevention Research World Health Organization | Ina Ronald and Epidemiology (BIPS) Bremen | WHO European Office for the Prevention Danquah Miah Head of Unit Lifestyle-Related Disorders | and Control of Noncommunicable Germany Diseases | Technical Officer | Russia Mansura M. Kassim Ministry of Agriculture of Natural Resources, Livestock and Fisheries | Deputy Principal Secretary |

Zanzibar Antje Kremlin Hebestreit Wickramasinghe 30 SUNDAY, OCTOBER 27

WORKSHOP

WS 02 EUROPEAN INITIATIVES FOR

SAAL 5 | OCEANIA HEALTH RESEARCH AND DEVELOPMENT 11:00 – 12:30

HOSTS

BioMed Alliance

Charité – Universitätsmedizin Berlin

M8 Alliance

Europe leads in many areas of research Global partnerships in health research and has developed powerful models create opportunities for enhanced of cross-border, cross-sectoral research learning, innovation and better health. cooperation. These have helped to in- Different models for participation, for crease the EU’s attractiveness as a place data sharing and leadership co-exist. for research and innovation, produced Through examples and stakeholders’ high-quality patents and created jobs and debate, the session aims to explore needs growth. The Scientific Panel for Health, and opportunities for future design of one of the expert groups tasked by the European health research and global Commission, has proposed the creation partnerships. of a European Council for Health Research to provide a comprehensive policy for health research in Europe, and facilitate cross-border collaboration. PROGRAM 31

CHAIRS

Chairman of the Executive Board | Bloch Pries PROGRAM, SUN 27 Germany

SPEAKERS

Gilles Bloch John P.A. Ioannidis INSERM | Chairman and CEO | Stanford Prevention Research Center |

France Director, Meta-Research Innovation Anne Britta Center at Stanford | Bucher Siegmund Anne Bucher United States of America European Commission | Director-General for Health and Food Safety | Einstein BIH Visiting Professor | France Germany

John P. A. Karin R. Ioannidis Sipido 32 SUNDAY, OCTOBER 27

PANEL DISCUSSION

PD 04 THE ROLE OF AI IN

SAAL 6 | EUROPE HEALTHCARE INNOVATION 14:00 – 15:30 Ethical Challenges of AI Innovation

HOST

EIT Health (European Institute for Innovation and Technology)

Numerous innovations that build on projects as test cases and interrogating Artificial Intelligence and other technolo- the potential practical utilization of these gies such as the internet of things and guidelines aims to identify how they can nanotechnologies are developing and be implemented and where shortcomings already getting adopted in the health and exist. This is a first in examining the care sectors. At the same time policy- concrete application of these guidelines makers internationally are under pressure in a highly relevant sector. The world is to address ethical challenges raised by closely following Europe’s path into ethics these technologies. Currently there is and AI, in terms of guidance and law. much focus on artificial intelligence. The Many are wondering whether this guid- European Commission’s High-Level Group ance will become as relevant internation- on Ethics and AI recently published their ally as Europe’s General Data Protection guidance. The incoming European Com- Regulation for privacy. mission President Ursula von der Leyen intends to put forward AI legislation in Immediately after the panel session, EIT the first 100 days of her mandate. Health will host a media session with the participation of Jan-Philipp, Paul Timmers EIT Health has volunteered to put the and Roberto Viola. We are expecting EU’s AI and ethics guidelines to the test. between 20 to 30 journalists to attend Utilising AI-related health innovation the session. PROGRAM 33

CHAIR

Paul Timmers University of Oxford | Chief Advisor EIT Health | United Kingdom

European Policy Centre | Senior Advisor | United Kingdom

Hila Hans

Azadzoy Hofstraat PROGRAM, SUN 27 SPEAKERS

Peter Dabrock Roberto Viola German Ethics Council | European Commission | Chair German Ethics Council | Director General of DG CONNECT Germany (Directorate General of Communication, Networks, Content and Technology) | Belgium Peter Roberto Dabrock Viola

Susanne Dehmel 34 SUNDAY, OCTOBER 27

PANEL DISCUSSION

PD 05 SECURING POLITICAL LEADERSHIP

SAAL 10 | ASIA FOR GLOBAL HEALTH TO 14:00 – 15:30 ACCELERATE THE ELIMINATION OF COMMUNICABLE DISEASES

HOST

UNITE

We are living a moment in history when Within this globalized frame of political we have most of the necessary tools action, a continuous process of evidence- and technologies needed to achieve based training for and by parliamentar- these ambitious goals, along with the ians is needed and this should be done at knowledge on where to continuously the global level. It is extremely important invest. Moreover, we have access to the that parliamentarians around the globe, intel provided by civil society and com- in a peer-to-peer approach, raise aware- munity-based organizations, mapping ness, share information, good practices, out the concrete needs of people living lessons learned and sustainable policies. with communicable diseases across the globe and pointing the direction on how Finally, it is equally important that this to end stigma and discrimination. debate is aligned with the UN 2030 Sustainable Development Goals Agenda In this context, parliamentarians are to assure that concrete actions to scale- called on to show their willingness to act up a human rights-based approach and ensure the translation of global and are followed. regional political commitments and declarations into life-changing policies that can potentially lead to the elimination of these diseases as global health threats. PROGRAM 35

CHAIR

Ricardo Baptista Leite UNITE | Founder & President | Portugal

KEYNOTE SPEAKER Ricardo Christine Baptista Leite Goffinet PROGRAM, SUN 27 Gunilla Carlsson UNAIDS | Executive Director a.i. | Switzerland

SPEAKERS

Alan Donnelly Esther Passaris

The G20 Health and Kenya National Assembly | Gunilla Esther Development Partnership | Convener Member of Parliament, Carlsson Passaris Nairobi City County | Former UK MP & MEP | Kenya United Kingdom UNITE | Member & Chapter Chair | Christine Goffinet Eastern and Southern Africa Berlin Institute of Health | BIH Professor for Virology | Jaak Peeters Germany Johnson & Johnson | Head of Global Public Health (GPH) | Alan Jaak Donnelly Peeters United States of America 36 SUNDAY, OCTOBER 27

PANEL DISCUSSION

PD 06 PROTECTING THE MENTAL HEALTH

SAAL 2 | AMERICA OF REFUGEES AND MIGRANTS 14:00 – 15:30 Challenges and Possible Solutions

HOSTS

Istanbul University Tehran University of Medical Sciences (TUMS) M8 Alliance University of Geneva Sapienza University

More people are on the move now than logical conditions emerging at each ever before. There are an estimated 1 billion phase of displacement and migration. migrants in the world today of whom In the first instance there may be trau- 258 million are international migrants and matic events that occur in the country 763 million internal migrants—one in seven of origin and may have even led to the of the world’s population. 65 million of the migration itself. Then the migrant may world’s internal and international migrants endure extreme environments, conditions are forcibly displaced today. This rapid or hardships throughout the migration increase of population movement has journey itself, including extended stays important public health implications, and in improvised camps with poor living therefore requires an adequate response conditions. Finally, there can be a whole from the health sector. Challenges to host of challenges to face in the country migrant health can be attributed to many of settling, a stage which perhaps least factors, including lack of access to health considered but most complex. Meanwhile, services, absence of financial protection, other challenges can be experienced and discrimination. at any and all stages, including stigma surrounding mental illness, access to Mental health is a key and highly complex good mental health care, continuity of facet of migrant health challenges with appropriate psychological care, loss of multiple drivers and associated psycho- loved ones, and the disconnect between PROGRAM 37

legal settlement status and care provid- Within this session the panel will discuss ers, which can result in an incomplete these challenges and the measures we course of treatment. can work towards to protect the mental health of migrants and refugees.

Antoine Santino CHAIRS Flahault Severoni PROGRAM, SUN 27

Santino Severoni WHO Regional Office for Europe, Public Health and Migration | Division of Policy and Governance for Health and Well-being | Regional Luciano Saso Coordinator Migration Health | Italy 38 SUNDAY, OCTOBER 27

PANEL DISCUSSION

WS 03 EVOLUTIONARY MEDICINE Holistic Perspectives for the Future of Global Health SAAL 4 | AFRICA 14:00 – 15:30

HOST

University of Zurich

Based on pioneering scientific concepts ance, epidemiological transitions in e.g., by Alexander von Humboldt (1769– disease and diet or the One Health initia- 1859) and Charles Darwin (1809–1882), tive are in the core of this new field of the emerging field of evolutionary medi- research. Future challenges such as pan- cine promotes a holistic view on the demics, climate change or socio-economic etiology and ultimate causalities of human misery call for the translation of these health and disease. Only by considering holistic science into real interventions. evolutionary and historic perspectives, is one able to design effective and sustain- The aim of this workshop is to highlight able global health polices for the future. and discuss the wide range of scientific and policy insights which can be gained No single problem in biomedicine can by looking at our common past. Global be profoundly addressed without taking health strategies without any knowledge the most fundamental system of nature— on past and current evolutionary trends evolution—into account. Technological are doomed to fail; thus insights from breakthroughs such as next-generation the panel experts shall contribute specifi- sequencing allow us finally to generate cally to novel factor analysis, to potential the needed big data of the human past. practical interventions and defining Complex issues such as antibiotic resist- globally-relevant guidelines. PROGRAM 39

CHAIR

Frank Rühli University of Zurich | Institute of Evolutionary Medicine, Faculty of Medicine | Founding Director and Chair | Switzerland

Patriciu Barbara

Achimas-Cadariu Natterson-Horowitz PROGRAM, SUN 27 SPEAKERS

Patriciu Achimas-Cadariu Denise Kühnert The Oncology Institute | Max Planck Institute for the “Prof. Dr. Ion Chiricuta” Cluj-Napoca | Science of Human History | Primary Physician in the Surgery Transmission, Infection, Diversification & Department Evolution Group (tide) | Group Leader | Germany Former Minister of Health | Maria S. Randolph Romania Barbara Natterson-Horowitz Guevara Nesse Harvard University | Department of Maria S. Guevara Human Evolutionary Biology | Doctors Without Borders | Visiting Professor Senior Operational Positioning and Advocacy Advisor | UCLA Division of Cardiology | Switzerland Professor of Medicine at David Geffen School of Medicine & Co-Director of Martin Hirsch UCLA Evolutionary Medicine Program | Ada Health GmbH | Co-Founder & Martin Frank United States of America Hirsch Rühli Chief Scientific Officer | Germany Randolph Nesse Arizona State University | Center for Evolution and Medicine | Founding Director | United States of America

Denise Kühnert 40 SUNDAY, OCTOBER 27

WORKSHOP

WS 04 TRADITIONAL MEDICAL PRACTICES

SAAL 5 | OCEANIA AND GLOBAL HEALTH 14:00 – 15:30

HOSTS

Kiel University

M8 Alliance

The WHO lists a high number of con costs and increased mortality is one ditions treated by acupuncture and of the biggest threats to global health, related “traditional medical practices” food security, and development today. that implicitly refer to three deadliest threats to global health today: 3. Due to the increasing misuse of pre- scription opioids and heroin, the pre 1. Currently, non-communicable diseases valence of opioid addiction is rapidly (NCDs, such as heart disease, stroke, increasing, physicians currently all cancer, chronic respiratory diseases over the world understandably have and diabetes) are among the leading questions about whether, when, and cause of mortality in the world. how to prescribe opioid analgesics for chronic and acute pain without 2. At the same time, a growing number of increasing public health risks. infections—such as pneumonia, tuberculosis, gonorrhea and salmonellosis— This workshop will address the active role are becoming harder to treat as the anti- of culture in health care and the impact biotics used to treat them become less of traditional medicines in diagnosis, effective. Antibiotic resistance leads prevention and treatment of these three to longer hospital stays, higher medical major threats in a very concrete sense. PROGRAM 41

CHAIRS

Angelika Messner Reinhard Schäfers Kiel University | Head of China Centre | World Health Summit | Ambassador | Germany Germany

Simon David

Barquera Napier PROGRAM, SUN 27 SPEAKERS

Simon Barquera David Napier National Institute of Public Health (INSP) | University College London | Director, Nutrition Policy Research | Professor of Medical Anthropology | Mexico United Kingdom

Ama de-Graft Aikins Yi-Chang Su

University of Ghana | Chinese Medical Advancement Ama Reinhard Dean of International Programmes | Foundation | President | de-Graft Aikins Schäfers Ghana Taiwan

Depei Liu Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC) | Former President | China

Depei Yi-Chang Liu Su

Angelika Messner 42 SUNDAY, OCTOBER 27

PANEL DISCUSSION

PD 07 SUSTAINABILITY OF

SAAL 6 | EUROPE HEALTHCARE SYSTEMS 16:00 – 17:30 Closing the Gap of Immunization

HOST

Sanofi

The Sustainable Development Goals offer the opportunity to understand what recognize the importance of vaccination works and potentially to adapt and repli- as a key health and development factor. cate evidence-based practices, including The immunization target: “Proportion on the adoption of innovative vaccines, of the target population covered by all technologies and digital solutions. vaccines included in their national Pro- gramme (3.b.1)” reflects the ability of a The event aims to: country to ensure access to vaccines and also to deliver them with high and equita- • Discuss the outcomes of the 2019 UN ble coverage. The UN High Level Meeting High-Level Meeting on Universal Health on Universal Health Coverage will restate Coverage (UHC) for greater action that vaccination is an essential health on immunization service and that there is no sustainable • Discuss the investment case for healthcare system without full child immu- vaccination and the broad benefit nization and life course immunization. of life course immunization, in light of its contribution to sustainability Still, coverage gaps are observed around of healthcare systems the world, linked to the complexity of the • Highlight the fundamentals of boosting implementation of vaccination strategies, research & development and innovation to lack of investment as well as to vaccina- in the vaccines field to tackle global tion hesitancy. The vaccination ecosystem health challenges is fragile: it involves multiple stakeholders • Call to action to closing the immuni who have to efficiently interact. Successful zation gap through multi-stakeholders’ vaccination program at national levels joined commitment PROGRAM 43

CHAIR

Mark Chataway Hyderus | Managing Director | United Kingdom

SPEAKERS Anne JP Bucher Sevilla PROGRAM, SUN 27 Anne Bucher JP Sevilla European Commission | Director-General Harvard T.H. Chan School of for Health and Food Safety | Public Health | Research Associate | Belgium United States of America

David Loew Soumya Swaminathan Sanofi Pasteur | Executive Vice President | World Health Organization (WHO) |

France Chief Scientist | Mark Soumya Switzerland Chataway Swaminathan Julio Daniel Mazzoleni Insfrán Minister of Health | Lothar H. Wieler Paraguay Robert Koch Institute | President | Germany

David Lothar H. Loew Wieler

Julio Daniel Mazzoleni Insfrán 44 SUNDAY, OCTOBER 27

PANEL DISCUSSION

PD 08 ACCELERATING INNOVATION

SAAL 10 | ASIA FOR I M PACT 16:00 – 17:30 Linking Innovations, Implementers and Investments to Drive Progress Towards SDG3

HOSTS

German Health Alliance (GHA)

UNAIDS

Progress on the Sustainable Development needs sustained partnership of commu Goals (SDGs) are uneven, and we are not nities, governments, innovators and the moving fast enough to reach the ambitious private sector that develop a shared 2030 goals. New technologies, service commitment to leave no one behind. delivery models and financing solutions are essential to reach universal health This high-level panel will serve as a forum coverage and other health related SDG- to explore what it takes to meaningfully targets. Innovations can play a key role create such linkages; how to build an for leaving no one behind. environment where health innovations can flourish and be linked to the needs While innovations are already transform- of countries. Panelists will highlight the ing the health, these do not always get importance of facilitating new coopera- adopted on scale to deliver impact. There tion models across countries and sectors. is a disconnect between innovators and They will identify ways to break down implementers that needs to be bridged. common barriers to accelerate uptake Leveraging innovations need the creation of innovations and how to nurture sus- of linkages between innovations, tech- tainability of national ecosystems. nologies, country needs and investments. The AIDS response has demonstrated that a multisectoral response that puts communities at the center is critical for success. Closing the gap to Health for All PROGRAM 45

CHAIR

Roland Göhde German Health Alliance (GHA) | Chairman of the Board | Germany

Founding Board Member & Co-Chair Switzerland Roland Michael of the Steering Committee | Göhde Oberreiter Lia Tadesse Germany State Minister of Health | Ethiopia

Tanya Lia Herfurth Tadesse 46 SUNDAY, OCTOBER 27

PANEL DISCUSSION

PD 09 RESPECT AND DIALOGUE Overcoming Barriers Between Sectors, Disciplines, and Cultures SAAL 2 | AMERICA 16:00 – 17:30

HOSTS

InterAcademy Partnership (IAP)

M8 Alliance

Tehran University of Medical Sciences (TUMS)

Sustaining peace is the central aim of the Many global crises are born or grow Sustainable Development Goals (SDGs) deeper due to the lack of comprehension and a necessary basis for all other SDGs, or limited interest and courage to reach including “Good Health and Well-being.” out across borders. Using health as an The initiative “Respect and Dialogue” entry point, the session will explore by the InterAcademy Partnership (IAP) barriers—between sectors, disciplines and intends to give science a stronger voice cultures—and how they can be overcome and take more responsibility in this to achieve progress towards the SDGs. regard. PROGRAM 47

CHAIRS

Edelgard Bulmahn Roberto Francesco Monti German Bundestag | Respect and Dialogue | Former Federal Minister and Managing Director | Former Vice President Italy of the German Bundestag | Edelgard Roberto Francesco Bulmahn Monti PROGRAM, SUN 27 Germany

SPEAKERS

Rana A. Hajjeh Mohammad Hossein Nicknam World Health Organization (WHO) | Iranian Academy of Medical Sciences | WHO Regional Office for Permanent Member | the Eastern Mediterranean | Iran Rana A. Mohammad Hossein Hajjeh Nicknam Director of Programme Management | Tolullah Oni Egypt University of Cambridge | Ali Jafarian MRC Epidemiology Unit | Tehran University of Medical Sciences Clinical Senior Research Associate | (TUMS) | Former Chancellor | United Kingdom Iran University of Cape Town |

World Health Summit | Honorary Associate Professor | Ali Tolullah International President 2019 South Africa Jafarian Oni 48 SUNDAY, OCTOBER 27

WORKSHOP

WS 05 FALSIFIED AND

SAAL 4 | AFRICA SUB-STANDARD MEDICINES 16:00 – 17:30 Detection, Prevention, and Response

HOST

Association of Research-Based Pharmaceutical Companies (vfa)

Falsified and substandard medicines are The purpose of this session is to first give a global problem that endangers the an overview and to analyse the scope of health and lives of patients. The WHO the global problem. Practical and locally estimates that about ten percent of all appropriate options to reduce the risk medicines in low- and middle-income of falsified and substandard medicines countries are falsified or substandard, entering the market will then be identified and in some regions the situation is even and discussed between different stake- much worse. High-quality medicines holder groups. Another focus is on are essential to protect patients and measures to identify such medicines prevent treatment failure. Risk reduction and ways to eliminate them. measures focus on identifying and eliminating falsified and substandard medicines in pharmaceutical markets. PROGRAM 49

CHAIR

Lutz Heide University of Tübingen | Professor of Pharmaceutical Biology | Germany

SPEAKERS Peter Mirfin Beyer Mpundu PROGRAM, SUN 27 Peter Beyer Mirfin Mpundu World Health Organization (WHO) | Ecumenical Pharmaceutical Senior Advisor | Network (EPN) | Executive Director | Switzerland Kenya

Alexandra Forster Shushan Tedla Bayer Healthcare | action medeor |

Head of Crime Defense | Quality Assurance and Alexandra Shushan Germany Pharmaceutical Consultancy | Forster Tedla Germany Lutz Heide University of Tübingen | Professor of Pharmaceutical Biology | Germany

Lutz Heide 50 SUNDAY, OCTOBER 27

WORKSHOP

WS 06 HOW MICROBIOMEDICAL RESEARCH

SAAL 5 | OCEANIA IS CHANGING MEDICINE 16:00 – 17:30

HOST

Max Delbrück Center for Molecular Medicine (MDC)

As we interact with our external environ- with immune components and/or dietary ment, so do we with our internal environ- risk factors, involve shared pathways ment. All mucosal surfaces, including impacted by the microbiota. Microbiomes intestines, mouth, airways, and urogenital act as asymptomatic reservoirs for oppor- tract, host complex microbial ecosystems. tunistic or antibiotic-resistant pathogens, These microbiomes differ between but causing symptomatic infectious disease persist within individuals, establish early when the right conditions (e.g. immuno- in life, and play crucial roles in processing suppression or antibiotic exposure) are met. nutrients, protecting from pathogens and priming the development of the immune Thus, microbiome analysis offers tools for system. Shared evolutionary history taught disease diagnosis and prognosis, personal- us to influence our microbiota, and our izing nutrition and drug treatment, epi- microbiota to influence us, including demiological monitoring, and risk assess- through immune and metabolite signaling. ment. Additionally, emerging therapeutics inspired by ancient practices draw on Diet, stress, antibiotic exposure, infection, microbiota through prebiotic, probiotic and other factors all can perturb the micro and microbiome transplant techniques. biota from a helpful eubiotic to harmful As diet and lifestyle shift, “Western” dysbiotic state. Dysbiosis contributes to diseases are quickly becoming global, complex diseases of the host, including threatening an enormous loss of healthy metabolic, renal, cardiovascular, inflam- lifetime. This calls for better understand- matory, autoimmune, neurological, and ing of the microbiota and translating this psychiatric states, also along a “gut-brain understanding into healthcare and life- axis.” Significant comorbidity between style advances in East and West, North, different progressive diseases, especially and South alike. PROGRAM 51

CHAIRS

Peer Bork Sofia Forslund The European Molecular Biology Max Delbrück Center Laboratory (EMBL) Heidelberg | for Molecular Medicine (MDC) | Head of Unit, Senior Scientist Forslund Lab | Group Leader | and Strategic Head of Bioinformatics | Germany Peer Mayaan Bork Levy PROGRAM, SUN 27 Germany

SPEAKERS Mayaan Levy Peer Bork University of Pennsylvania | The European Molecular Biology UPENN Department of Microbiology | Laboratory (EMBL) Heidelberg | LevyLab | Principal Investigator | Head of Unit, Senior Scientist Sofia Stephan Patrick United States of America Forslund Rosshart and Strategic Head of Bioinformatics | Germany Stephan Patrick Rosshart University Medical Center Freiburg | Eran Elinav Translational Microbiome Research Weizmann Institute of Science | and Gnotobiotic Mouse Facility | Department of Immunology | ElinavLab | Principle Investegator and Group Leader | Principal Investigator | Germany Israel Julie Segre Eran Julie Stanley Hazen Elinav Segre National Human Genome Cleveland Clinic | Research Institute | Translational and Department of Cardiovascular & Functional Genomics Branch | Metabolic Sciences | Chair | Chief and Senior Investigator United States of America National Human Genome Research Institute | Microbial Genomics Section | Head |

United States of America Stanley Hazen 52 SUNDAY, OCTOBER 27

KEYNOTE

KEY 01 OPENING CEREMONY SAAL 1 RUDOLF VIRCHOW 18:00 – 19:30

HOSTS

M8 Alliance

World Health Summit

CHAIR

Detlev Ganten World Health Summit | President | Germany PROGRAM 53

SPEAKERS

Charles Ibingira Tolullah Oni Makerere University | University of Cambridge | University College of Health Senior Research Medical Officer |

David Loew Sanofi Pasteur | Executive Vice President | France

Charles Bernd Ibingira Montag 54 OPENING CEREMONY AND RECEPTION

SUNDAY, OCTOBER 27 18:00 55

PROGRAM

MONDAY, OCTOBER 28 56 MONDAY, OCTOBER 28

PANEL DISCUSSION

PD 10 UNIVERSAL HEALTH COVERAGE Expanding Rights and Access SAAL 6 | EUROPE 9:00 – 10:30

HOSTS

Global Solutions Initiative The Graduate Institute Geneva – Global Health Center M8 Alliance UHC2030

SDG 3.8 on universal health coverage The recognition of social participation is (UHC) envisions that by 2030 all people also reflected in the strong engagement can use the health services they need, of civil society in the UHC 2030 multi- of sufficient quality to be effective, and stakeholder platform. Strengthening without facing financial hardship. Despite accountability and advocacy are central strong international support for UHC, to accelerate progress towards universal country level financing and implementa- health coverage. tion remains challenging. Multi-sectoral The role for the private sector in achiev- approaches involving the whole of gov- ing UHC remains subject to much debate. ernment and society are key to generate One reason stems from the multiple and political will for investment in UHC and complex processes implicated in achiev- drive appropriate reforms. ing UHC. While the overarching aim of Ensuring equitable access to universal UHC is to ensure that everyone has access health coverage has many dimensions. to affordable and quality health products New models are emerging around the and services regardless of background, world which ensure inclusiveness by in practice this requires strengthening strengthening social participation. These health financing for and service provision include new mechanisms like people’s of, an agreed package of basic health health assemblies and other forms of services across a broad population. Yet participation that ensure citizens and there remains no blueprint for how this patients voices in the setting of priorities. might be accomplished. PROGRAM 57

CHAIR

Ilona Kickbusch The Graduate Institute of International and Development Studies | Global Health Center | Chair of the International Advisory Board | Switzerland

UHC 2030 | Co-Chair Margaret Frederik Chan Kristensen

SPEAKERS

UHC 2030 | Co-Chair

Ilona Kickbusch 58 MONDAY, OCTOBER 28

PANEL DISCUSSION

PD 11 FROM WORDS TO ACTION:

SAAL 10 | ASIA TRANSFORMING MENTAL HEALTH 9:00 – 10:30 G LO B A L LY

HOST

Harvard Medical School

Mental health problems affect us all. the likely impact of this historic oppor The massive unmet need for care, the tunity to transform mental health globally, abuses of fundamental rights of people such as the limited leadership capacity; with mental health problems, and the the lack of a workforce equipped with very low investment in mental health skills to deliver psychosocial interventions; care nationally and through development the lack of accountability and metrics assistance, are unacceptable. Quite to evaluate the impact of mental health simply, mental health is the orphan child care systems; the rising burden of mental of the health care system and all coun- health problems in young people; and tries are developing when it comes to the limited agency and voice of persons mental health. No country will achieve the with mental health problems. aspirations of universal health coverage without addressing mental health, for This panel will engage stakeholders health care cannot be universal without representing diverse sectors of society mental health. who need to act in concert to address these barriers and invite them to respond Even as there is growing global and to how these barriers, and others which national political will to invest in mental impede progress, need to be addressed health, several structural barriers impede to transform words into action. PROGRAM 59

CHAIR

Vikram Patel Harvard Medical School | The Pershing Square Professor of Global Health | United States of America

Devora Antonella Kestel Santuccione Chadha SPEAKERS

7 Cups | Head of Mental Health Priority Area | Moriarty Sunkel PROGRAM, MON 28 Founder & Chief Executive Officer | United Kingdom United States of America

Antonella Santuccione Chadha Roche Diagnostics | Global Medical Manager for Alzheimer’s Disease | Switzerland

Co-Founder and the CEO | Vikram Miranda Patel Wolpert Women’s Brain Project 60 MONDAY, OCTOBER 28

PANEL DISCUSSION

PD 12 BRIDGING R&D AND SUSTAINABLE

SAAL 2 | AMERICA ACCESS TO ANTIBIOTICS 9:00 – 10:30

HOST

Global Antibiotic Research & Development Partnership (GARDP)

Antimicrobial resistance (AMR) is a major Earlier this year, the Global Antibiotic global health and development issue and Research and Development Partnership a threat to achieving the SDGs. One of (GARDP) in collaboration with the World the challenges is to ensure that patients Health organization (WHO) and the across the world can benefit from new and Medicines Patent Pool (MPP) organized existing antibiotics that are developed, a technical meeting on bridging R&D made accessible and used appropriately. and sustainable access of antibiotics. The Tackling this challenge requires a holistic meeting sought to understand the roles approach involving many players. and responsibilities of different players including developers, regulators, govern- Access and stewardship considerations ments and civil society. Building on the have to be an integral part of the R&D outcomes of the technical meeting this process from the beginning. The starting high level panel will explore practical point should be public health driven target solutions to questions such as: product profiles taking into account public health and patient needs. A major 1. What does sustainable access mean, challenge is how to ensure that new who is responsible for which elements? treatments are accessible, affordable 2. What are the fundamental elements and appropriately used on a global level. R&D needs to consider to ensure While huge progress has been made in access? the R&D process, the access challenge 3. To bridge R&D and access, what inter- remains largely unsolved. ventions are needed at global and national levels, and who pays for it? PROGRAM 61

CHAIR

Imogen Foulkes BBC | Journalist | Switzerland

SPEAKERS Manica Imogen Balasegaram Foulkes Manica Balasegaram Thomas Cueni Global Antibiotic Research and International Federation of Pharma Development Partnership (GARDP) | ceutical Manufacturers & Associations Executive Director | (IFPMA) | Director-General | United Kingdom Switzerland

Peter Beyer Mirfin Mpundu

World Health Organization (WHO) | Ecumenical Pharmaceutical Network Peter Mirfin

Senior Advisor | (EPN) & ReAct Africa | Beyer Mpundu PROGRAM, MON 28 Switzerland Executive Director & Head | Sweden

Thomas Cueni 62 MONDAY, OCTOBER 28

WORKSHOP

WS 07 NEGLECTED TROPICAL DISEASES

SAAL 4 | AFRICA AND INCLUSION UNDER THE UMBRELLA 9:00 – 10:30 OF UNIVERSAL HEALTH COVERAGE

HOSTS

Association of Research-based Pharmaceutical Companies (vfa)

Eberhard-Karls-University Tuebingen

German Network against Neglected Tropical Diseases (DNTDs)

German Society for Tropical Medicine and International Health (DTG)

Universitätsklinikum Tuebingen

Untreated, many neglected tropical A key question is to ask how can UHC diseases can lead to impairment and be utilized for the fight of NTDs and disability. 80 percent of people with the benefit for people with disabilities. disabilities are living in developing coun- Important contributions could be the tries, they are among the poorest and expansion of laboratory capacities and most marginalized people. The Global the support of health-related supply Goals for Sustainable Development put chains. The workshop would like to a strong focus on equity and universal focus on multisectoral interventions. health coverage. Often health systems are not able to deal with diseases hitting the poorest layers in societies and for which cheap medication is available. PROGRAM 63

CHAIRS

Achim Hörauf Carsten Köhler Bonn University Medical Center | Institute for Tropical Medicine, Institute of Medical Microbiology, Travel Medicine and Human Parasitology Immunology and Parasitology | Director | at the University and Germany University Hospital of Tübingen | Sahayarani Mwelecele Ntuli Antony Malecela Center of Competence | Director | Germany

SPEAKERS

Sahayarani Antony Grace Mwasuka DAHW German Leprosy and DAHW German Leprosy and Tuberculosis Relief Association | Tuberculosis Relief Association | Achim Grace

Hörauf Mwasuka PROGRAM, MON 28 Department of Social Affairs | Tanzania Inclusion Advisor | Yao Sodahlon Germany Mectizan Donation Program | Director | Louise Kelly-Hope United States of America Liverpool School of Tropical Medicine | Kirsty Thompson Centre for Negleted Tropical Diseases | CBM Australia | Strategic Advisor | Head of Monitoring and Evaluation Australia Operational Research | Louise Yao Kelly-Hope Sodahlon United Kingdom

Mwelecele Ntuli Malecela World Health Organization (WHO) | WHO Regional Office for Africa | Director of Department of Control of Neglected Tropical Diseases | Republic of the Congo Carsten Kirsty Köhler Thompson 64 MONDAY, OCTOBER 28

WORKSHOP

WS 08 CLIMATE CHANGE

SAAL 5 | OCEANIA AND PUBLIC HEALTH 9:00 – 10:30 Environmental Threats, Challenges, and Solutions for the Next Generation

HOSTS

Charité – Universitätsmedizin Berlin Potsdam Institute for Climate Impact Research M8 Alliance Stiftung Mercator

Rising global temperatures are causing shop will take a look at the challenges major physical, chemical, and ecological which climate change poses to public changes to the planet. Knowledge of health, and analyze what lessons can be these broad effects, known as “climate learned from existing political initiatives in change,” has been present in academic the area of environmental health. Consid- circles for many years, and there is wide ering the threats climate change poses consensus among scientific organizations to human health, safety, and security, and climatologists that they are the result children are a vulnerable group at par- of human activity. The threats which ticularly high risk. The WHO Initiative climate change poses to human health, “Pollution Free Environment for Healthy for current and future generations, has Generations” has been working to pre- also been thoroughly analyzed and the serve the social foundations of children’s necessity to act in the name of public mental and physical health, which are health has been emphasized by medical further threatened by the specter of far- associations and institutions. reaching effects of unchecked climate change, including community and global Today, an unprecedented wave of global instability, mass migrations, and increased activism among the young population conflict. Furthermore, non-communicable provides a new window of opportunity to diseases have been reported to increase move from science to action—but the among children, and according to the question of how to get there is currently Developmental Origins of Health and a matter of intense discussion. This work- Disease (DOHaD) hypothesis, early life PROGRAM 65

environmental exposures are one of the more physical activity. The public sup- possible causes. port generated by these short-term changes can become a driving force Considering these threats of climate of long-term sustainability goals and change and pollution to public health and have immediate impact upon our shared looking for possible opportunities and environment. Therefore, the workshop Sabine Chisato solutions, transportation is a central issue. will take a look at the issue of transpor Gabrysch Mori A move towards sustainable transport tation to further discuss possible ways would not only help stop climate change, to move from knowledge to solutions it would produce immediately noticeable to political action. effects such cleaner air, less noise, and

CHAIR Andrew Maria

Eckart von Hirschhausen Haines Neira PROGRAM, MON 28 Physician, Comedian, and Scientist for Future | World Health Summit Ambassador | Germany

SPEAKERS

Sabine Gabrysch Christian Hochfeld Charité – Universitätsmedizin Berlin Agora Verkehrswende | Christian Eckart and Potsdam Institute for Climate Executive Director | Hochfeld von Hirschhausen Impact Research (PIK) | Germany Professor for Climate Change and Health | Chisato Mori Germany Chiba University | Center for Preventive Andrew Haines Medical Sciences | Director | London School of Hygiene & Tropical Japan Medicine (LSHTM) | Professor of Environ- Maria Neira mental Change and Public Health | World Health Organization (WHO) | United Kingdom Public Health, Environmental and Social Determinants of Health | Director | Switzerland 66 MONDAY, OCTOBER 28

KEYNOTE

KEY 02 TRANSFORMING HUMAN CAPITAL SAAL 1 Investing in Health and Education RUDOLF VIRCHOW 11:00 – 12:30

HOSTS

M8 Alliance

National University of Singapore (NUS)

The UN high-level political declaration There is an emerging opportunity to link on UHC, adopted in September 2019, investments in education, skills, and jobs sets out a clear agenda on the attainment in the health sector with the broader work of SDG3. One of the major challenges of human capital and social spending, identified in the declaration is how to engaging the international financing accelerate investments in the health institutions and all relevant partners as workforce to overcome the global short- necessary. Investing in jobs in the health ages predicted by 2030, especially in sector will positively impact generations countries with the weakest PHC systems to come: contributing to improved popu- and the furthest from UHC. This requires lation health and creating opportunities building the necessary foundations for for millions of women and youth to be PHC: investments in core infrastructure, active participants in the labor market. both health facilities and preservice education institutions, and in health worker By linking health employment, human employment, retention and productivity. capital and social spending the world can accelerate more and better investments in people for greater health equity and economic growth. PROGRAM 67

CHAIR

John Eu-Li Wong The National University Health System | Chief Executive | Singapore

SPEAKERS Mark Julie Lyn Britnell Hall Mark Britnell Tom Catena KPMG | Aurora Humanitarian Initiative | Chair | Global Chairman & Senior Partner | Armenia United Kingdom Julie Lyn Hall Jim Campbell International Federation of Red Cross World Health Organization (WHO) | and Red Crescent Societies (IFRC) |

Director, Health Workforce Department | Chief of Staff | Director of the Jim John Eu-Li

Switzerland Office of the Secretary General | Campbell Wong PROGRAM, MON 28 Special Advisor for Health | Switzerland

Tom Catena 68 MONDAY, OCTOBER 28

PANEL DISCUSSION

PD 13 A COMPREHENSIVE APPROACH

SAAL 6 | EUROPE TO GLOBAL HEALTH AND SECURITY 11:00 – 12:30 The Example of the Current Ebola Outbreak, Health Crises in Armed Conflicts

HOSTS

German Federal Foreign Office

German Federal Ministry of Defense

West Africa’s Ebola pandemic five years perspectives. How are the humanitarian ago taught the international community aid response and the security sector an important lesson in dos and don’ts of intertwined? What are the challenges comprehensive health crisis management. NGOs are facing on the ground? What is It became clear that health crises encom- the role and interest of different actors? pass a security dimension—especially in fragile contexts, an upcoming health Nowadays it is with no doubt, that such crisis can destabilize a country or a whole complex emergencies demand compre- region. Assuming its responsibility in hensive crises management—in assess- preventing and resolving health crises, ment, evaluation, and implementation. Germany has been revising and adapting But when it comes to concrete action, its health crises management ever since. what are the limits of a comprehensive approach towards health crises? How to The Ebola outbreak in Eastern Congo interact with different actors? is an example of the new challenges we are facing—a complex set of actors in a The panel aims at raising awareness for conflict situation, a variety of militias and the security dimension of health crises/ armed groups with very different interests. disease outbreaks in fragile contexts and seeks to improve the understanding for In the light of the current Ebola outbreak different perspectives on comprehensive the panelists will discuss German health health crises response and preparedness. crises management from their different PROGRAM 69

CHAIR

Carlo Masala Bundeswehr University Munich | Director of the Pilot Project Metis | Germany

SPEAKERS Jane Ruth Carlo Aceng Masala Jane Ruth Aceng Hans-Ulrich Holtherm Minister of Health | Medical Academy of the German Armed Uganda Forces | Director of Military Medicine Science and Capability Development | Susanne Baumann Germany Federal Foreign Office | Federal Government Commissioner Michael Ryan for Disarmament and Arms Control | World Health Organization (WHO) | Susanne Michael

Director-General for International Order, Health Emergencies Programme | Baumann Ryan PROGRAM, MON 28 the United Nations and Arms Control | Executive Director | Germany Switzerland

Ruxandra Draghia Mercedes Tatay Merck Sharp & Dohme Corp. | Doctors Without Borders | Vice President Public Health & International Medical Secretary | Scientific Affairs, Global Vaccines | Switzerland

United States of America Ruxandra Mercedes Draghia Tatay

Hans-Ulrich Holtherm 70 MONDAY, OCTOBER 28

WORKSHOP

WS 09 HOW TO ENSURE SUSTAINABLE

SAAL 4 | AFRICA ELIMINATION OF NTDS 11:00 – 12:30 A Focus on Sleeping Sickness

HOSTS

Drugs for Neglected Diseases initiative (DNDi)

Sanofi

Neglected Tropical Diseases (NTDs) Effective control can be achieved when affect more than one billion people and selected public health approaches are cost developing economies billions of combined and delivered locally. Imple- dollars every year. Bold and concerted mentation of appropriate measures with action is needed to alleviate the burden high coverage contribute to achieving of these diseases of poverty. In 2011, the the targets of the WHO NTD roadmap WHO Strategic and Technical Advisory on neglected tropical diseases, resulting Group for Neglected Tropical Diseases in the elimination of many and the eradi- and partners adopted a roadmap for cation of at least two by 2020. This might control, elimination, and eradication. be the case for sleeping sickness.

No one organization, government, or However, we must be vigilant: a lower company can do it alone. To realize the number of cases poses a challenge to the vision of this roadmap, 13 bio-pharma way the disease has to be tackled. Last ceutical companies, under the leadership cases are the most difficult to reach; of WHO, joined their efforts with the priority shifts to other diseases; donors’ Bill and Melinda Gates Foundation and “fatigue” can be observed. To avoid risk of numerous partners. Together they signed rebound and reach sustainable elimination, the London Declaration, the largest it is essential to further invest while ensur- coordinated effort to date for stronger ing optimal use of resources, to explore and commitment, better coordination and implement innovative strategies, including strengthened collaboration. for sentinel case management, to shift towards stronger local accountability. PROGRAM 71

CHAIR

Samantha Bolton Communication and Advocacy Advisor | Switzerland

SPEAKERS Luc Mwelecele Ntuli Kuykens Malecela Luc Kuykens Mwelecele Ntuli Malecela Sanofi | Senior Vice President World Health Organization (WHO) | Global Health Programs | WHO Regional Office for Africa | United States of America Director of Department of Control of Neglected Tropical Diseases | Estrella Lasry Republic of the Congo Doctors Without Borders |

Tropical Disease Advisor | Erick Mwamba Miaka Estrella Nathalie

Spain Ministry of Health | Program Director | Lasry Strub-Wourgaft PROGRAM, MON 28 Democratic Republic of the Congo Veerle Lejon Research Institute Nathalie Strub-Wourgaft for Development (IRD) | Drugs for Neglected Diseases Research Director | initiative (DNDi) | France Director of Neglected Tropical Diseases | Switzerland

Veerle Lejon 72 MONDAY, OCTOBER 28

WORKSHOP

WS 10 THE SDG3 GLOBAL ACTION PLAN

SAAL 5 | OCEANIA FOR HEALTH AND WELLBEING 11:00 – 12:30 Are We Ready for a Change in Mindset—One Health as an Accelerator

HOSTS

German Federal Ministry of Education and Research (BMBF)

Lancet Commission on One Health

In 2018, the heads of three governments, countries according to their priorities.” Germany, Norway, and Ghana, got to He called upon stakeholders to stop gether to launch the Global Action Plan thinking in silos, and he continued by for SDG3, which included an appeal to saying; “The letter I received asks for the Director-General of the World Health more than a new strategy. It demands Organization (WHO), Dr. Tedros Adhanom a change in mindset.” Ghebreyesus and other key stakeholders to rally behind it. In Berlin, at the World Along the lines of Dr. Tedros, the Lancet Health Summit 2018, ten United Nations’ One Health Commission would like to organizations active in global health, with continue with tangible action on the call WHO as the lead, took up the challenge for a change in mindset by harnessing and expressed assurance of their full the long-standing and continued collabo- commitment to the Global Action Plan for ration in global health between Germany, SDG3. In the same session at the World Norway, and Ghana. We ask for the in- Health Summit 2018, a framework for this volvement and leadership of these three Action Plan was presented by Dr. Tedros countries and beyond in the current identifying accelerators, e.g. sustainable Lancet One Health Commission, which, financing, primary health care, R&D, at its core, calls for multi-disciplinarity; innovation and access. The Director- a radical change in mindset. We will General of WHO stated the following: explore at various levels from grassroot “Global coordination is good, but we also to ministerial whether One Health has need coordination at the country level: the potential of becoming an accelerator unity amongst partners to support to the Global Action Plan. PROGRAM 73

CHAIRS

John Amuasi Andrea Winkler Lancet Commission Lancet Commission on One Health | Co-Chair | on One Health | Co-Chair | Ghana Germany Kwaku Maria Lothar H. Agyeman-Manu Jahrmann Bjerke Wieler

SPEAKERS

Anthony Nsiah Asare Kwaku Agyeman-Manu Ghana Health Service | Minister of Health | Director General | Ghana Ghana Hélène Carabin Bernhard Schwartländer Université de Montréal | John Anthony Andrea World Health Organization Amuasi Nsiah Asare Winkler PROGRAM, MON 28 Canada Research Chair in (WHO) | Chief of Staff | Epidemiology and One Health | Switzerland Canada Camilla Stoltenberg Wendy Harrison Norwegian Institute of Schistosomiasis Control Public Health | Director General | Initiative – SCI Foundation | Norway Chief Executive Officer | United Kingdom Lothar H. Wieler Hélène Bernhard Carabin Schwartländer Robert Koch Institute | Maria Jahrmann Bjerke President | Ministry of Health and Care Germany Services | State Secretary | Norway

Wendy Camilla Harrison Stoltenberg 74 MONDAY, OCTOBER 28

PANEL DISCUSSION

PD 13a ENTREPRENEURS IN

SAAL 6 | EUROPE GLOBAL HEALTH PRESENTATION 12:45 – 13:45

From 12:45 – 13:45, startups will showcase innovative ideas, with short presentations followed by audience Q&A.

In partnership with Stiftung Charité and the Charité BIH Entrepreneurship Summit. PROGRAM 75

CHAIR

Daniel Trattler Eobiont GmbH | Creative Director | Germany

Business Development Manager | Germany Janna Verena

Germany Hachmann Schöwel PROGRAM, MON 28 Verena Schöwel Maria Levin MyoPax | Neteera | Director of Business Research Fellow and Physician | Development & Marketing | Germany Israel

Maria Daniel Levin Trattler 76 MONDAY, OCTOBER 28

WORKSHOP

WS 10a THE ONE HEALTH CONCEPT On a Consensus Seeking Mission SAAL 5 | OCEANIA 12:30 – 14:00

HOST

Lancet Commission on One Health

The One Health approach aims at demon- and private sectors, research institutions strating the synergistic benefit and added and governments, to implement effective value of an integrated approach to human solutions to complex issues of global and animal health as well as environmental concern. A One Health approach is neces- science, thereby dismantling the discipli- sary to inform a coordinated response to nary silos which continue to persist, for the aforementioned health threats. the benefit of the ecosystems that support human, animal, and plant life. One Health The two chairs for the session are on a is closely aligned with the Sustainable consensus seeking mission by exploring Development Goals and is intrinsically a) the prevailing views on One Health, inter- and trans-disciplinary. In an inter b) the notion of paradigm shift in One dependent world, health sector actors are Health and c) the approach towards less likely to achieve their goals without translating the One Health concept into efficient multi-disciplinary collaboration. politics and society. They will invite panelists from the various components Global health threats such as climate of One Health to engage in a thought- change, emerging infectious disease epi- provoking discussion. Output from the demics, neglected diseases of poverty, panel discussion will feed into the current antimicrobial resistance, non-communica- Lancet One Health Commission. ble diseases, in addition to food security and nutrition, require coordinated action across multiple disciplines. One Health policies and programs involve both public PROGRAM 77

CHAIRS

John Amuasi Andrea Winkler Lancet Commission Lancet Commission on One Health | Co-Chair | on One Health | Co-Chair | Ghana Germany John Barbara Amuasi Natterson-Horowitz

SPEAKERS

Timo Falkenberg Barbara Natterson-Horowitz Center for Development Research | Harvard University | Coordinator One Health Graduate School | Department of Human Evolutionary Germany Biology | Visiting Professor

Kim Grützmacher UCLA Division of Cardiology | Timo Chris

Wildlife Conservation Society | Professor of Medicine at David Geffen Falkenberg Walzer PROGRAM, MON 28 Wildlife Health Program | School of Medicine & Co-Director of Program Manager | UCLA Evolutionary Medicine Program | United States of America United States of America

Jürgen May Chris Walzer Bernhard Nocht Institute Wildlife Conservation Society | for Tropical Medicine | Wildlife Health Program |

Head of the Department of Executive Director | Kim Andrea Infection Epidemiology | United States of America Grützmacher Winkler Germany Jakob Zinsstag-Klopfenstein Swiss Tropical and Public Health Institute (TPH) | Deputy Head of the Department of Epidemiology and Public Health | Switzerland

Jürgen Jakob Zinsstag- May Klopfenstein 78 MONDAY, OCTOBER 28

KEYNOTE

KEY 03 FOCUS AFRICA SAAL 1 Building Capacities and Strong Institutions RUDOLF VIRCHOW 14:00 – 15:30

HOSTS

M8 Alliance

Makerere University

United Nations Member States have political commitment to invest in health a shared commitment and a common in a number of African countries. New interest in achieving the Sustainable institutions have been built—such as the Development Goals by 2030. Achieving African Centers for Disease Control— this will require significant investment, and primary health care is in the focus. innovation and partnerships in Africa. There are new initiatives to support It will benefit from integrated approaches African-led innovation coalitions and to health, development and security, as innovative funding platforms and to well as consensus-building, information strengthen research institutions. This sharing and knowledge exchange. requires additional investments in science, technology, and innovation in Africa to The African Union has made health one improve health, spur economic growth, of its priorities and we see increasing and reduce poverty across the continent. PROGRAM 79

CHAIR

Charles Ibingira Makerere University | University College of Health Sciences | Principal | Uganda

SPEAKERS Jane Ruth Maria Aceng Flachsbarth Jane Ruth Aceng Maria Flachsbarth Minister of Health | Federal Ministry for Economic Uganda Cooperation and Development (BMZ) | Parliamentary State Secretary | Kwaku Agyeman-Manu Germany Minister of Health | Ghana Jayasree K. Iyer Access to Medicine Foundation | Thomas Cueni Kwaku Charles Executive Director | Agyeman-Manu Ibingira PROGRAM, MON 28 International Federation of Pharma The Netherlands ceutical Manufacturers & Associations (IFPMA) | Director-General | Switzerland

Thomas Jayasree K. Cueni Iyer 80 MONDAY, OCTOBER 28

PANEL DISCUSSION

PD 14 ARTIFICAL INTELLIGENCE

SAAL 6 | EUROPE FOR HEALTH 14:00 – 15:30 How to Ensure Quality?

HOSTS

Berlin Institute of Health (BIH)

Fraunhofer Heinrich-Hertz-Institut

This session includes representatives which are based on several continents. of universities, research institutes, multi Despite these differences, all participants national corporations, federal agencies, in the session share a common goal: non-profit organizations, and intergov- ensuring that AI solutions for health are ernmental bodies (ITU/WHO FG-AI4H), safe for patient use. PROGRAM 81

CHAIR

Thomas Wiegand Fraunhofer Heinrich-Hertz-Institute | Executive Director | Germany

ITU/WHO Focus Group on “AI for Health” (FG-AI4H) | Chair

Khair Soumya ElZarrad Swaminathan SPEAKERS

Khair ElZarrad Bernd Montag FDA’s Center for Drug Evaluation Siemens Healthineers | and Research (CDER) | President and CEO | Deputy Director of the Office Germany of Medical Policy (OMP) | Soumya Swaminathan United States of America World Health Organization (WHO) | Stefan Christof

Bernd Montag 82 MONDAY, OCTOBER 28

WORKSHOP

WS 11 HOW CAN HEALTH INSURANCE SCHEMES

SAAL 4 | AFRICA HELP TO DEVELOP SUSTAINABLE HEALTH 14:00 – 15:30 SYSTEMS IN THE BRICS COUNTRIES? Looking for Sustainable Health Systems

HOST

Manipal Academy of Higher Education

The (BRICS) countries Brazil, Russia, The session has two aims: First, to inform India, China, and South Africa share about the concept of BRICS, the health similar problems regarding the founda- status and the recent health care reforms tion of sustainable health (care) systems in those countries. Second, to foster a even if their economic and political discussion about the different possibilities systems often do not develop in parallel. and approaches to move to sustainable The BRICS countries already work to- health systems in the BRICS countries gether in different health organizations by means of health insurance schemes. like the World Health Organization (WHO). A point of discussion will also be how this The start of an own development bank can contribute to reach the Sustainable (The new Development Bank) now offers Development Goals (SDGs) in these new ways in cooperation. Recent political countries. developments like the start of the world biggest health insurance schema in India— often called Modi-Care—and South Africa being under new management open new windows of opportunities. PROGRAM 83

CHAIR

Helmut Brand Prasanna School of Public Health, Manipal | Founding Director | India

SPEAKERS Theuns Alicia Botha Matijasevich Manitto Harsh Bhardwaj Alicia Matijasevich Manitto Public Policy Research Centre (PPRC) | University of São Paulo | Research Associate Research Associate | Department of Preventive Medicine, India Faculty of Medicine | Associate Professor | Brazil Theuns Botha MediCoop CFI | Managing Director Alexey Morozov

Voronezh State Medical University Former Health Minister of Western Cape | Qiao Alexey N.N. Burdenko | Jianrong Morozov PROGRAM, MON 28 South Africa Head of the Department for Education, Qiao Jianrong International Affairs, and Public Relations | World Health Organization | Russia China Representative Office | Hélène Rossouw Coordinator, Health Systems and Spear Health Foundation | CEO | Health Security | South Africa China Helmut Hélène Brand Rossouw 84 MONDAY, OCTOBER 28

WORKSHOP

WS 12 PRIORITIZING INFECTIOUS DISEASES

SAAL 5 | OCEANIA FOR SURVEILLANCE IN AFRICA 14:00 – 15:30 Revisiting Integrated Disease Surveillance and Response (IDSR)

HOST

Helmholtz Centre for Infection Research (HZI)

In 1998, the World Health Organization Such a revision facilitates the process Regional Office for Africa( WHO/AFRO) of updating the list of diseases under adopted the Integrated Disease Surveil- surveillance in the African context of the lance and Response (IDSR). Currently, this IDSR and contributes to the advancement strategy is under revision in order to adjust of the topic of surveillance tool allocation for new developments, including advance- to a certain disease. ments in infectious disease research, changes in the burden of specific diseases, The findings of this workshop shall set recent experience with Ebola epidemics the basis for the development of a ge- as well as the increasing availability of new neric concept that will allow countries digital technologies. and regions on any continent to prioritize diseases for surveillance and also to The objective of this workshop is to revisit identify the most appropriate surveillance the criteria and procedures applied to system for each of them, thereby pro assign a specific surveillance method to viding an evidence-based, reproducible a specific disease with a strong focus on and localizable process that also supports the African setting and recent advances and complements the current revision of eHealth applications for surveillance. of the IDSR. PROGRAM 85

CHAIRS

Olúṣọlá Aruna Gérard Krause Public Health England | Helmholtz Centre for Infection Senior Public Health Advisor | Research (HZI) | Head of United Kingdom Department for Epidemiology | Germany Olawunmi Maria da Luz Ambrose Otau Adeoye de Lima Mendonça Talisuna

SPEAKERS

Olawunmi Adeoye Peter Nsubuga Nigeria Centre for Disease Control | Global Public Health Solutions | Nigeria Medical Epidemiologist | United States of America Justus Benzler Olúṣọlá Mazala Anders

Robert Koch Institute | Michael Ryan Aruna Kapina Wallensten PROGRAM, MON 28 Epidemiological Advisor to the World Health Organization German Electronic Notification, (WHO) | Health Emergencies Reporting and Information System Programme | Executive Director | for Infectious Disease Control | Switzerland Germany Ambrose Otau Talisuna Natalia Margarita Cediel Becerra World Health Organization De La Salle University | (WHO) | Regional Office Justus Peter Lecturer and Researcher | for Africa | Advisor, IHR & Benzler Nsubuga Colombia Global Health Security | Republic of the Congo Maria da Luz de Lima Mendonça National Institute of Public Health Anders Wallensten of Cape Verde | President | Public Health Agency of Sweden | Cape Verde Deputy State Epidemiologist | Sweden Mazala Kapina Zambia National Public Health Natalia Margarita Michael Cediel Becerra Ryan Institute | Head Surveillance and Disease Intelligence | Zambia 86 MONDAY, OCTOBER 28

PANEL DISCUSSION

PD 15 ACCESS TO MEDICINES The Role of Partnerships in Finding Solutions SAAL 6 | EUROPE 16:00 – 17:30

HOST

International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

SDG 3 seeks to ensure healthy lives and do to ensure both innovation and access promote well-being for all, and SDG 17 especially for essential and neglected seeks strengthening global partnerships treatments? How do communities see between public, private, and government these partnerships? agencies as an essential ingredient in ensuring a brighter and healthier future. A panel of leaders of public health partnerships from differing treatment fields So how are public-private partnerships and with different business models have meeting these goals both for innovation been brought together to discuss these and access? What are the key features challenges and seek to explain how their of “innovative business models” and how partnerships are making real impact in do these models and the cooperation achieving SDGs especially in developing with the private sector and other stake- countries. holders meet expectations? What can we PROGRAM 87

CHAIR

Greg Perry International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Assistant Director General | Switzerland

Cary Thoko Adams Elphick-Pooley KEYNOTE SPEAKER

Eva Njenga NCD Alliance of Kenya | Chair | Kenya

SPEAKERS

Cary Adams Catharina Boehme Manica Eva

Union for International Cancer Control Foundation for Innovative Balasegaram Njenga PROGRAM, MON 28 (UICC) | Chief Executive Officer | New Diagnostics (FIND) | CEO | Switzerland Switzerland

Manica Balasegaram Thoko Elphick-Pooley Global Antibiotic Research and Uniting to Combat NTDs | Director | Development Partnership (GARDP) | United Kingdom Executive Director |

United Kingdom Martin Greg Bernhardt Perry Martin Bernhardt Sanofi | General Medicines & Emerging Markets | Head of Global Public Affairs | Switzerland

Catharina Boehme 88 MONDAY, OCTOBER 28

PANEL DISCUSSION

PD 16 SMART INVESTMENT IN

SAAL 10 | ASIA EQUITABLE HEALTH SYSTEMS 16:00 – 17:30 At the Intersection of Science and Policy

HOSTS

ATscale – Global Partnership for Assistive Technology

Ottobock SE & Co. KgaA

The George Washington University, Milken Institute School of Public Health

The world has never possessed such Smart investments and efficient health a sophisticated arsenal of interventions system development must be the center and technologies for curing disease and piece of health policies and financing. prolonging life. Yet the gaps in health It is time to evaluate both the perfor- outcomes continue to widen. For much mance of health systems to serve those of the ill health, disease, premature death, most in need, especially in low and middle and suffering we see on such a large income countries, but also explore how scale effective and affordable interven- best to support them in the future. This tions are available for prevention and panel will discuss these issues in a frank treatment. The power of existing inter and provocative way. ventions is not matched by the capacity of health systems to deliver them to those in greatest need, in a comprehensive way, and on an adequate scale. PROGRAM 89

CHAIR

Adnan A. Hyder The George Washington University | Milken Institute School of Public Health | Senior Associate Dean for Research and Professor of Global Health | United States of America Jane Ruth Abdul Aceng Ghaffar

SPEAKERS

Jane Ruth Aceng Abdul Ghaffar Minister of Health | Alliance for Health Policy and Systems Uganda Research | Executive Director | Switzerland Reinhard Busse

Technische Universität Berlin (TU) | Berit Hamer Reinhard Berit

Department of Health Care Ottobock SE & Co. KGaA | Busse Hamer PROGRAM, MON 28 Management | Director | Director International Cooperation | Germany Germany

Alison End Fineberg ATscale – Global Partnership for Assistive Technology | Director | Switzerland

Alison Adnan A. End Fineberg Hyder 90 MONDAY, OCTOBER 28

PANEL DISCUSSION

PD 17 THE LIFE-SAVING POWER OF

SAAL 2 | AMERICA MOBILE TECHNOLOGY 16:00 – 17:30 Achieving Universal Health Coverage and Financial Risk Protection through Mobile Money

HOSTS

Heidelberg Institute of Global Health (HIGH)

Charité Global Health

Despite widespread introduction of user this revolution followed mobile payment fee exemption policies, out-of-pocket services, also known as mobile money payments remain the predominant mode (MM), acting as an alternative to cash. for households in sub-Saharan Africa to cater for the costs of healthcare. However, Owing to its potential to provide users healthcare expenditures often exceed with rapid access to cash and remit the available assets and savings of a low- tances, electronic savings accounts, and income household. In addition, poor house- insurance schemes, MM is increasingly holds have no assured regular income or being used in the health sector and collateral to secure a loan, thus prevent- multiple services using MM have been ing insurance companies and financial launched in several countries, however institutions from providing their services with mixed results. to these potentially high-risk customers. This session aims to highlight best Within less than a generation, mobile practice examples from the field and communication has become ubiquitous. to determine potential benefits and During the last 10 years, mobile phone implications of using MM and related ownership more than doubled in low- services to achieve financial risk protec- and middle-income countries and quad- tion as a key component of universal rupled in sub-Saharan Africa. Alongside health coverage (UHC). PROGRAM 91

CHAIR

Till Bärnighausen Heidelberg Faculty of Medicine of the University Heidelberg | Director of Heidelberg Institute of Global Health (HIGH) | Germany

Ann Roland Aerts Göhde SPEAKERS

Joep Lange Institute | Director of Public Health Department | Till Natalia

Director for Global Health Diplomacy | Madagascar Bärnighausen Pshenichnaya PROGRAM, MON 28 The Netherlands

Roland Göhde German Health Alliance (GHA) | Chairman of the Board | Germany

Christoph Diana Benn Ratsiambakaina 92 MONDAY, OCTOBER 28

WORKSHOP

WS 13 CAPACITY BUILDING IN HEALTH RESEARCH

SAAL 4 | AFRICA IN LOW-RESOURCE SETTINGS 16:00 – 17:30 How Can Funders and Implementers Better Coordinate Capacity Building Efforts in Sub-Saharan Africa

HOSTS

European & Developing Countries Clinical Trials Partnership (EDCTP)

German Federal Ministry of Education and Research (BMBF)

Institut Pasteur

There is a wide range of initiatives, national overcrowding of projects and funder- as well as multi-lateral, aiming at strength- driven initiatives in a few institutions, ening health research capacity in resource countries and activity areas, while other limited countries, in particular on the locations and capacity gaps are com- African continent. Many of these initiatives pletely forgotten. generate important and noticeable results, but often in isolation and with little plan- This session will explore how the current ning for long-term sustainability. myriad of capacity building initiatives can be better coordinated among Coordination between different funders funders, and between funders and reci is mostly lacking, or modest at best, and pient countries. The session will bring the different programs are often devel- together a diverse group of organizations oped and implemented without consid- involved in different aspects of capacity eration of mutual reinforcement, leading strengthening, on both the demand and inadvertently to competition, duplication supply side. We will discuss whether an or repetition. There is currently no easy improved or de novo platform, such as way to access, deposit, and share infor- an on-line Open Capacity Strengthening mation about existing or upcoming Platform, can be established that would programs and events, which would allow allow funders and implementers to share individual organizations to design a new information and coordinate their efforts initiative that is compatible with existing towards a more balanced and cost-effi- initiatives. The end result is too often cient use of resources. PROGRAM 93

CHAIRS

Ole Olesen Leonardo Simão European & Developing Countries Former Minister of Health and Clinical Trials Partnership (EDCTP) | Former Minister of Foreign Affairs Director of International Cooperation | and Cooperation | The Netherlands Mozambique Hannah Dermot Akuffo Maher

SPEAKERS

Hannah Akuffo Hans Hagen Swedish International Development Institut Pasteur Center for Global Health | Cooperation Agency – Sida | Deputy Director of the Senior Specialist, Centre for Global Health | Unit for Research Cooperation, France Imelda Ole

Bates Olesen PROGRAM, MON 28 Dept for Partnerships & Innovation | Dermot Maher Sweden World Health Organization (WHO) | Imelda Bates Coordinator | Liverpool School of Tropical Medicine | Switzerland Clinical Haematologist | Marcel Tanner United Kingdom Swiss Academy of Sciences (SCNAT) |

Kundai Chinyenze President | Kundai Leonardo International AIDS Vaccine Initiative Switzerland Chinyenze Simão (IAVI) | Executive Medical Director | Kenya

Hans Marcel Hagen Tanner 94 MONDAY, OCTOBER 28

WORKSHOP

WS 14 REFORMING HEALTH SYSTEMS Health Policy as Social Policy SAAL 5 | OCEANIA 16:00 – 17:30

HOSTS

Hertie School

Robert Bosch Stiftung

Health promotion and protection for used to make health policy an integral all citizens and healthcare for patients part of modern social policy and meet represent some of the most important growing challenges. Health governance policy challenges worldwide. Virtually involves state, market, non-governmental, every single area of life—professional professional, and individual actors often productivity, cultural creativity, political working across sectors and depends and social participation, and citizens’ on interactions at multiple levels—from quality of life—is influenced by the state local clinics to global forums. The session of health at the individual and at the traces the development of health govern- population level. But are current forms ance institutions and actors, examines of health governance and healthcare factors influencing the health-related services sufficient to overcome inequal decisions of individuals and policy- ities, ensure health security, harness makers alike, highlights innovations both technological developments, and cover at international level and at the inter future needs? section between individuals and professionals, and offers recommendations to The session focuses on health govern- ensure that health care and health policy ance and the models and strategies are governed to meet future challenges. PROGRAM 95

CHAIR

Mujaheed Shaikh Hertie School | Professor of Health Governance | Germany

SPEAKERS Kalipso Julio Daniel Chalkidou Mazzoleni Insfrán Kalipso Chalkidou Bernadette Klapper Center for Global Development | Robert Bosch Stiftung | Director of Global Health Policy & Senior Vice President Health | Senior Fellow | Germany United Kingdom Julio Daniel Mazzoleni Insfrán Francesca Colombo Minister of Health |

Organization for Economic Cooperation Paraguay Francesca Mujaheed and Development (OECD) | Colombo Shaikh PROGRAM, MON 28 Claus Wendt Head of the Health Division, University of Siegen | Directorate for Employment, Labour Chair of Sociology of Health and and Social Affairs | Healthcare Systems | Professor | France Germany

Bernadette Claus Klapper Wendt 96 WORLD HEALTH SUMMIT NIGHT

MONDAY, OCTOBER 28 18:00 97

PROGRAM

TUESDAY, OCTOBER 29 98 TUESDAY, OCTOBER 29

PANEL DISCUSSION

PD 18 THE COMMERCIAL DETERMINANTS

SAAL 6 | EUROPE OF HEALTH 9:00 – 10:30

HOST

Tobacco Free Portfolios

The human right to health cannot be As the power of the corporate sector protected by doctors and the healthcare continues to rise, now is the time to forge sector alone. The biggest threats to partnerships for change, to better human human health, the diseases and illnesses health globally. In the spirit of the 17th that take too many lives are intertwined Sustainable Development Goal—Partner- with commerce. Noble intentions to lift ships for the Goals—this session profiles the health of all must address the com- the new and necessary relationships mercial realities of business interests that that are developing between health and see millions affected by widely available commerce, it gives hope of what can and legal products. be achieved when different sectors start speaking the same language and work together with a clear vision. PROGRAM 99

CHAIR

Bronwyn King Tobacco Free Portfolios | CEO | Australia

SPEAKERS Don Pavan Gerritsen Sukhdev Don Gerritsen Pavan Sukhdev Principles for Responsible Investment WWF International | President | (PRI) | Head of Benelux | India The Netherlands Ulana Suprun Mark Saunders Former Acting Minister of Health | AIA Group Limited | Ukraine Group Chief Strategy and Ruben Zandvliet Bronwyn Ulana Corporate Development Officer | King Suprun ABN AMRO Bank N.V. | Hong Kong Advisor for Environmental, Social, and Ethical Risk and Policies | The Netherlands

Mark Ruben

Saunders Zandvliet PROGRAM, TUE 29 100 TUESDAY, OCTOBER 29

PANEL DISCUSSION

PD 19 CLIMATE CHANGE AND HEALTH Science Guiding Policy and Practice SAAL 10 | ASIA 9:00 – 10:30

HOSTS

German National Academy of Sciences Leopoldina e.V.

InterAcademy Partnership (IAP)

Impacts of climate change on human (EASAC) completed a report analyzing health have begun to attract greater evidence on climate change and health attention. However, there is much still in Europe: covering both direct and to be done to use the current evidence indirect risks in terms of hazards, expo- base to inform policy development sure and vulnerabilities. Project work broadly across sectors, and to fill gaps clarifying options for adaptation and in the knowledge base by new research. mitigation and the implications for Pathways of health effects are complex overcoming barriers to implementation with many factors interacting, and climate led to a range of recommendations for change will intersect with other major generating and using science to guide trajectories e.g. in urbanization, popula- policy and practice. tion ageing and human behavioral change. This World Health Summit session will discuss key points relating to the impacts Academies of science worldwide have of climate change for health, stimulated significant interest in the issues for under- by this recent work with particular regard standing and addressing the impacts of to identifying policy needs and actions climate change. Recently, the European and to extending academies’ analysis Academies Science Advisory Council worldwide. PROGRAM 101

CHAIR

Volker ter Meulen InterAcademy Partnership (IAP) | President | Germany

SPEAKERS Robin Maria Fears Nilsson Robin Fears Johannes Klumpers European Academies Science European Commission | Advisory Council | Directorate-General for Research Bioscience Programme Secretary | and Innovation | Head of Unit – United Kingdom Chief Scientific Adviser – SAM, EGE | Belgium Andrew Haines

Johannes

Klumpers PROGRAM, TUE 29 102 TUESDAY, OCTOBER 29

PANEL DISCUSSION

PD 20 ACCESS TO QUALITY HEALTH CARE FOR

SAAL 2 | AMERICA WOMEN IN LOW RESOURCE SETTINGS 9:00 – 10:30 Global Strategies to Overcome Gaps and to Identify Solutions

HOSTS

Charité – Universitätsmedizin Berlin

M8 Alliance

By 2030 85% of NCD-related deaths its partners to develop well trained health among women will occur in low- to workforce at all levels of care so that middle-income settings. Reasons are women get access to quality care. the failure of health systems to offer adequate and equal access to health care. A way forward will be given by taking the Gaps in access to up to date knowledge example of the emerging North-South and continuous education for health and South-South network of academia professionals and the lack of tools for which is supporting the “End cervical quality control are the main underlying Cancer” strategy of WHO in the African causes. Region. This network will establish close to client training centers for health care The panel will provide insight into the providers in several North- and Sub- problems health care professionals are Saharan African countries. These plat- facing in low- and middle-income settings forms of knowledge exchange for cervical in their struggle to provide quality care cancer will be best positioned to be for women. An overview will be provided expanded for the dissemination of knowl- about the global strategies of WHO and edge for all key areas of women health. PROGRAM 103

CHAIR

Jalid Sehouli Charité – Universitätsmedizin Berlin | Department of Gynecology | Medical Director | Germany

Maria Princess Nothemba Flachsbarth Simelela SPEAKERS

Maria Flachsbarth Princess Nothemba Simelela Federal Ministry for Economic World Health Organization (WHO) | Cooperation and Development (BMZ) | Special Adviser to the Director-General, Parliamentary State Secretary | Strategic Programmatic Priorities | Germany South Africa

Sean Kehoe Ibrahima Teguete Sean Ibrahima University of Birmingham | Lawson Tait Centre Hospitalo-Universitaire Kehoe Teguete Professor of Gynaecological Cancer | Gabriel Touré | United Kingdom Obstetrician and Gynecologist | Mali Frank Kornely Boehringer Ingelheim International | Andreas Ullrich Senior International Product Manager | Charité – Universitätsmedizin Berlin | Germany Department of Gynecology |

Visiting Scientist | Frank Andreas Germany Kornely Ullrich PROGRAM, TUE 29

Jalid Sehouli 104 TUESDAY, OCTOBER 29

WORKSHOP

WS 15 HOW CAN WE CREATE

SAAL 4 | AFRICA SUSTAINABLE VALUE FOR PATIENTS 9:00 – 10:30 AND SOCIETY? Healthcare Sustainability From Theory to Practice

HOST

European University Hospital Alliance

The European University Hospital Alliance treatments 5 or 10 years later? How invites you to explore how adding value sustainable is the added value? What to individuals and society is possible in a does it mean not only for the individual, sustainable way. Over the past few years but also for society? How do we feedback it has become clear that sustainability is these long term results back to decision not just a buzzword but a dire necessity. making at the start of treatment?

How does healthcare approach this Doing more with less can only be part of challenge? Healthcare creates a lot of the answer. At the World Health Summit, value; our health is one of our most our panel looks forward to discuss with important assets. Health innovation you how we can achieve a balanced brings us increasingly advanced knowl- approach that aligns the social, economic edge and technological solutions. and environmental resources and improve health outcomes. But we are also a resource intense sector, e.g. the NHS is the UK’s largest employer The European University Hospital Alliance and our university hospitals are often big (EUHA) brings together nine of Europe’s organizations with large environmental leading University Hospitals. They envision footprints. to be a network of sustainable healthcare eco-systems that achieve the best out- So far we have mainly analyzed our short comes for our patients within the resources term results, but what is the effect of our available, also in the long run! PROGRAM 105

CHAIR

Heyo Kroemer Charité – Universitätsmedizin Berlin | CEO | Germany

SPEAKERS Jan Sir Robert Hazelzet Lechler Jan Hazelzet Sir Robert Lechler Erasmus University Medical Center | King’s Health Partners | Professor Healthcare Quality Executive Director and Outcomes | King’s College London | The Netherlands Provost and Senior Vice President (Health) | Maria Margarete Karsten United Kingdom Charité – Universitätsmedizin Berlin | César Velasco Muñoz Maria Margarete César Specialist in Gynaecology and Obstetrics | Karsten Velasco Muñoz Agency for Health Quality and Assessment Germany of Catalonia (AQuAS) | Director | Spain

Heyo

Kroemer PROGRAM, TUE 29 106 TUESDAY, OCTOBER 29

WORKSHOP

WS 16 CO-CREATION AND CO-OWNERSHIP

SAAL 5 | OCEANIA OF THE UHC AND SDG AGENDAS 9:00 – 10:30 NTDs as a Litmus Test

HOST

Drugs for Neglected Diseases initiative (DNDi)

The proof of quality universal health policies and services. The global commu- coverage will be it the extent to which nity has just launched its Global Action it is able to reach all people, where they Plan to achieve SDG3, which includes plans live, and deliver the best possible care to accelerate research and innovation. with optimal existing and new tools, which are affordable and accessible, This workshop will brainstorm how to and do not place undue burden on the ensure neglected populations at the health system or upon primary care center of the implementation of the UHC givers. In many countries, the test will and SDG agendas, so that areas of criti- be the extent to which quality UHC can cal importance to assure needs driven be delivered to neglected and vulnerable innovation and access are designed with populations, including those living with and around them. The workshop will NTDs. scrutinizing existing efforts—including platforms, partnerships and coalitions— A presupposition that their needs can for the extent to which they involve and be responded to is that their needs are co-create policies with affected popu known. A test of that is their involvement lations, and draw on lessons these can in the creation and implementation of share for the implementation of UHC and contribute to achieving the SDGs. PROGRAM 107

CHAIR

Nathalie Strub-Wourgaft Drugs for Neglected Diseases initiative (DNDi) | Director of Neglected Tropical Diseases | Switzerland

Michael Nathalie Devoy Strub-Wourgaft SPEAKERS

Michael Devoy Javier Sancho Mas Bayer AG | Executive Vice President Barcelona Institute for Global Health for Medical Affairs & Pharmacovigilance (ISGlobal) | Coordinator of the Global and Bayer Chief Medical Officer | Chagas Disease Coalition | Germany Spain

Michael Makanga Monique Wasunna Michael Monique European & Developing Countries Drugs for Neglected Diseases initiative Makanga Wasunna Clinical Trials Partnership (EDCTP) | (DNDi) Africa | Director of the DNDi Executive Director | Africa regional Office | The Netherlands Kenya

Javier

Sancho Mas PROGRAM, TUE 29 108 TUESDAY, OCTOBER 29

PANEL DISCUSSION

PD 21 TACKLING UNMET MEDICAL NEEDS

SAAL 6 | EUROPE OF VULNERABLE AND 11:00 – 12:30 NEGLECTED POPULATIONS Accelerating R&D of Innovative and Effective Medical Interventions Through Partnerships and Strategic Alliances

HOSTS

Charité – Universitätsmedizin Berlin

European & Developing Countries Clinical Trials Partnership (EDCTP)

M8 Alliance

Max Planck Institute for Infection Biology

Despite much progress, poverty related es in resource-limited settings, to support infectious diseases (PRDs) are still preventive measures as well as reducing responsible for a huge burden in Africa. unnecessary referrals and ensuring early As well as their impact on individuals, initiation of treatment when needed. these diseases—in particular, tuberculosis, HIV/AIDS and malaria—and the neglected To optimally contribute to clinical deci- and emerging diseases, impose a high sion-making and working practices in economic burden on countries, acting as existing healthcare systems, it is impor- a drag on national development. Achiev- tant to evaluate the effectiveness of ing most if not all Sustainable Develop- promising new generations of medical ment Goals (SDGs) will depend on effec- technologies in real life situations. More tive control of infectious diseases through over, antimicrobial resistance (AMR) is enhanced detection, treatment, preven- already having a major impact in develop- tion and tracking of infection. The devel- ing countries especially in Africa, com- opment of fast, reliable, user-friendly and promising the use of multiple antibiotics cost-effective medical technologies is against target pathogens, as well as needed to streamline diagnostic process- antimalarial, antiviral and antifungal PROGRAM 109

therapeutics. Key to reducing the threat This session will discuss general strate- of AMR is the development of better gies and provide practical examples diagnostic and prognostic tools, ideally of the clinical development of novel for use at point-of-care. medical technologies for PRDs through partnerships and strategic alliances.

Stefan Peter Kaufmann Sands CHAIRS

Stefan Kaufmann Michael Makanga Max Planck Institute European & Developing Countries for Infection Biology | Director | Clinical Trials Partnership (EDCTP) | Germany Executive Director | The Netherlands

Angela Soumya Loyse Swaminathan SPEAKERS

Angela Loyse Soumya Swaminathan St George’s University of London | World Health Organization (WHO) | Institute of Infection and Immunity | Chief Scientist | Honorary Infectious Diseases Consultant | Switzerland United Kingdom Veronika von Messling Catherine K. Ohura Federal Ministry of Education Michael Veronika Makanga von Messling PROGRAM, TUE 29 GHIT Fund | CEO and Executive Director | and Research (BMBF) | Japan Life Sciences Division | Director General | Germany Peter Sands The Global Fund to Fight AIDS, Tuber Gerhard Walzl culosis and Malaria | Executive Director | Stellenbosch University | Switzerland Immunology Research Group | Head | South Africa Catherine K. Gerhard Ohura Walzl 110 TUESDAY, OCTOBER 29

PANEL DISCUSSION

PD 22 GLOBAL PUBLIC HEALTH SECURITY The Role of National Public Health Institutes in Monitoring Threats SAAL 10 | ASIA 11:00 – 12:30

HOSTS

Centre on Global Health Security, Chatham House

International Association of National Public Health Institutes (IANPHI)

Robert Koch Institute

There is a wealth of data being collected the national and global levels, it is impera- at the national level across a range of tive that NPHIs are able to first access indicators, monitoring and evaluation available and relevant existing data. This tools, and programs, however mechanisms session has a dual focus on the evolving are not always in place to allow effective role of NPHIs in mandating and advocat- use of this data in decision-making for ing for better preparedness and on the national health security and preparedness. governance of data for health, reflecting Further, the barriers to accessing data on the value of existing data across the from within the health sector, as well as health and non-health sectors and the data that is relevant to the health sector challenges to more effective use of data but collected by non-health actors, are to empower the NPHIs. poorly characterized at a national and subnational level. The Centre on Global Health Security, in collaboration with three NPHIs in Nigeria, Director of the Africa Centers for Disease Ethiopia and Pakistan, is leading a project Control, Dr. John Nkengasong, urged to Strengthen National Accountability Member States to establish and strengthen and Preparedness for Global Health Se- their National Public Health Institutes curity (SNAP-GHS). This project provides (NPHIs) as a matter of health security. a springboard for the proposed panel To optimally use information to strengthen discussion, inviting the Directors of the health security and preparedness at both Nigeria Centre for Disease Control and PROGRAM 111

the Ethiopian Public Health Institute to Robert Koch Institute and the Inter engage in the topic and session focus national Association of NPHIs). (along with key project partners, the

CHAIR Emmanuel Beyene Agogo Moges Lothar H. Wieler Robert Koch Institute | President | Germany

SPEAKERS

Emmanuel Agogo Beyene Moges Nigeria Centre for Disease Ethiopian Public Health Institute (EPHI) | Ngozi Ebere Control (NCDC) | Deputy Director, Deputy Director General | Erondu Okereke Prevention and Programs | Ethiopia Nigeria Ebere Okereke Ngozi Erondu Public Health England | Castlepines Medical Foundation | Consultant in Global Public Health CEO, Project Zambezi | Public Health England | Lead, PHE IHR United Kingdom Strengthening Programme | Meerjady Sabrina Flora United Kingdom Meerjady Sabrina Lothar H. Flora Wieler PROGRAM, TUE 29 The International Association of National Elhadj As Sy Public Health Institutes (IANPHI) | International Federation of Red Cross Vice-President of IANPHI | and Red Crescent Societies (IFRC) | France Secretary General | Rüdiger Krech Switzerland World Health Organization (WHO) | Universal Health Coverage and Health Systems | Director | Rüdiger Elhadj As Krech Sy Switzerland 112 TUESDAY, OCTOBER 29

PANEL DISCUSSION

PD 23 HEALTH DATA AS A

SAAL 2 | AMERICA GLOBAL PUBLIC GOOD 11:00 – 12:30

HOSTS

Fondation Botnar

The Lancet & Financial Times Commission: Growing Up in a Digital World: Governing Health Futures 2030

New technologies are emerging and Ultimately, while there is a significant converging to create a new infrastructure opportunity to leverage AI and health that acts as a central nervous system of data for global health, especially in low- the global community, allowing data to and middle-income countries, nothing be shared instantly across regions, bor- is guaranteed unless we create the need- ders, and oceans. The current and future ed global regulatory environment for convergence of big health data—from health data to become a global public personal, clinical, and environmental— good. This session will explore the oppor- combined with artificial intelligence( AI) tunities as well as critical challenges offers unprecedented opportunities for donors, governments and development public health. Pooling and sharing this partners currently face when implement- data have the potential to reduce the ing initiatives where they are collecting barriers to accessing diagnostics and care, valuable data, and to begin thinking how making it available to all. If we act now, we can find solutions at different levels we can create a whole new health data to urgently coordinate action in the move ecosystem as part of the digital revolu- toward health data becoming a global tion, enabling it to become a global public public good and consider if it is time to good. If we don’t, we risk that self-inter- put in place an international health data ested groups take advantage and use regulation through the World Health this data for commercial gain, and in the Assembly? worst case, for malicious purposes. PROGRAM 113

CHAIR

Stefan Germann Fondation Botnar | Chief Executive Officer | Switzerland

SPEAKERS Anurag Nanjira Agrawal Sambuli Anurag Agrawal Joanne Waldstreicher CSIR Institute of Genomics & Johnson & Johnson | Integrative Biology | Director | Chief Medical Officer | India United States of America

Marelize Gorgens Thomas Wiegand World Bank Group | Fraunhofer Heinrich Hertz Institute |

Health, Nutrition and Population Executive Director | Stefan Joanne Global Practice | Senior Monitoring Germany Germann Waldstreicher and Evaluation Specialist | United States of America

Nanjira Sambuli World Wide Web Foundation | Senior Policy Manager | United States of America

Marelize Thomas

Gorgens Wiegand PROGRAM, TUE 29 114 TUESDAY, OCTOBER 29

WORKSHOP

WS 17 ACCESS TO SUSTAINABLE

SAAL 4 | AFRICA NCD TREATMENT AND CARE 11:00 – 12:30 Finding Solutions Through Public-Private Partnerships in Low-Resource Settings

HOSTS

Boehringer Ingelheim Pharma GmbH & Co. KG

The Defeat-NCD Partnership

The rising tide of non-communicable This panel discussion, an official side diseases (NCDs) represents one of the event of the World Health Summit 2019, greatest public and global health chal- will explore: lenges of our times. We have arrived at a tipping point with NCDs and it is • How can public-private partnerships time to tip the scales in our favour. lead to improved access to medicines and technologies? Enormous effort has been directed by • How can public-private partnerships many concerned actors into advocacy, help scale up services for NCD treat- sensitising policy makers, and creating ment and care? public awareness. But impact is too slow. We must scale up concrete action and provide the NCD prevention and management services that people with NCDs need right now. PROGRAM 115

CHAIR

Juliette Foster Journalist | United Kingdom

SPEAKERS Mukul Myint Bhola Htwe Mukul Bhola Devora Kestel The Defeat-NCD Partnership | World Health Organization (WHO) | Chief Executive | Director of Mental Health and Substance Switzerland Abuse | Switzerland

Maria Flachsbarth Antonio Ruffolo Federal Ministry for Economic Boehringer Ingelheim

Cooperation and Development (BMZ) | Corporate Center GmbH | Maria Devora Parliamentary State Secretary | Head of Access to Healthcare Flachsbarth Kestel Germany and Global Health Policy | Germany Diane Gashumba Minister of Health | Nikhil Seth Rwanda United Nations Institute for Training and Research (UNITAR) | Myint Htwe Executive Director | Minister for Health and Sports | Switzerland Myanmar Juliette Antonio Foster Ruffolo PROGRAM, TUE 29

Diane Nikhil Gashumba Seth 116 TUESDAY, OCTOBER 29

WORKSHOP

WS 18 THE SDG3 GLOBAL ACTION PLAN

SAAL 5 | OCEANIA FOR HEALTH AND WELLBEING 11:00 – 12:30 Local Solutions—How International Funders Can Support National Health Priorities

HOST

Wellcome Trust

The goal of the workshop will be to dis- There is a need to understand why this cuss how international funders can sup- occurs and shed light on alternative port domestic health priorities and ensure aid challenging that provide sustainable, that receiving governments see develop- demand-driven and long term-financ- ment assistance for health (DAH) as a ing. The workshop will explore different tool to complement their own agendas. perspectives and lessons learned on funding innovation mechanisms that put The Global Action Plan for Healthy Lives countries decision making at the heart and Well-Being for All, launched at of the process, including by exploring UNGA in September 2019, highlights some opportunities for co-funding models. common issues in the global health land- Hearing from country representatives, scape. One of the key problems that multilateral agencies, bi-lateral donors hinder sustainable and equitable progress and research funders, participants will is the lack of involvement of countries discuss the barriers to identify the essen- that receive DAH in shaping international tial features of these models and how programs and funding mechanisms. This to overcome them. has meant that in some cases, international funded programs were not seen as a way to meet the health priorities of the receiving country and that external flows have had a substitution effect for domestic resources. PROGRAM 117

CHAIR

Mark Chataway Hyderus | Managing Director | United Kingdom

SPEAKERS Mark Chinwe Lucia Chataway Ochu Alex Harris Chinwe Lucia Ochu Wellcome Trust | Nigeria Centre for Disease Control | Head of Global Policy & Advocacy | Deputy Director Prevention & United Kingdom Programmes Coordination

John Markels Nigeria Centre for Disease Control | Merck Sharp & Dohme Corp. | Head, Research, Training &

President, Global Vaccines | Knowledge Management | John Toomas United States of America Nigeria Markels Palu

Rosemary Mburu Toomas Palu Waci Health | Executive Director | World Bank Group | Kenya Advisor for Global Coordination | Switzerland

Rosemary

Mburu PROGRAM, TUE 29 118 TUESDAY, OCTOBER 29

WORKSHOP

WS 19 BETTER LEADERSHIP:

SAAL 4 | AFRICA IMPROVED HEALTH 12:30 – 14:00 Young Physician Leaders: “The Leadership We Want”

HOSTS

ESMT European School of Management and Technology GmbH

InterAcademy Partnership (IAP)

Successful institutions need good leaders. The InterAcademy Partnership (IAP) And whether they are in high income Young Physician Leaders (YPL) program countries or poorer countries, institutions aims to bridge this gap. Launched in 2011, providing healthcare, educating future to date some 213 young physicians from physicians or promoting the public’s some 45 countries have participated in health are no different. Yet decision- eight international and two regional makers in such institutions are often editions of this personalized leadership appointed from among people trained training program (a dedicated IAP for in medicine, with little formal training Health YPL Directory is available here: in leadership to prepare them for these http://www.interacademies.org/37944/ roles. YPL-Directory). PROGRAM 119

CHAIRS

Jo Ivey Boufford Peter McGrath International Society for InterAcademy Partnership (IAP) | Urban Health (ISUH) | President | Program Officer | United States of America Italy Jo Ivey Peter Nora Ilona Grasselli Boufford McGrath ESMT European School of Management and Technology GmbH | Program Director | Germany

SPEAKERS Nora Ilona Selected from among the 2019 cohort Grasselli of Young Physician Leaders PROGRAM, TUE 29 120 TUESDAY, OCTOBER 29

WORKSHOP

WS 20 NEW VOICES

SAAL 5 | OCEANIA IN GLOBAL HEALTH 12:30 – 14:00 The (Dis)connection between Science and Global Health

HOSTS

Global Young Academy

World Health Summit

This New Voices in Global Health session challenges, which usually require inter is organized by Global Young Academy. disciplinary expertise and collaboration. It aims to explore the (dis)connection The speakers and hosts of the session are of various sciences with global health members and alumni of the Global Young research, policy, or advocacy. Scientists’ Academy, with backgrounds in chemistry, from diverse disciplines discuss how their biomedical sciences, nano-chemistry, work relates to global health and share food engineering, health sciences, and how their field relates to broader global the history and philosophy of science. PROGRAM 121

CHAIRS

Stefan Kohler Koen Vermeir Global Young Academy | Global Young Academy | Co-lead, Global Health Working Group | Co-chair, Executive Committee | Germany Germany Muhammad Akhyar Guru Farrukh Madhavan

SPEAKERS

Muhammad Akhyar Farrukh Guru Madhavan Forman Christian College | U.S. National Academy of Engineering | Associate Professor | Norman R. Augustine Senior Scholar Pakistan and Director of Programs | United States of America Almas Taj Awan Almas Taj Wibool Federal University of Sao Carlos | Wibool Piyawattanametha Awan Piyawattanametha Visiting Professor | King Mongkut’s Institute of Technology Brazil Ladkrabang (KMITL) | Director of Advanced Imaging Research Center | Mohamed Elhadidy Thailand Zewail City of Science and Technology | Associate Professor Arya Shalini Subash of Biomedical Sciences | Engineering School of Lorena (EEL), USP |

Egypt Post Doctoral Fellow | Mohamed Arya Brazil Elhadidy Shalini Subash PROGRAM, TUE 29

Stefan Koen Kohler Vermeir 122 TUESDAY, OCTOBER 29

KEYNOTE

KEY 04 HEALTH IS A SAAL 1 POLITICAL CHOICE RUDOLF VIRCHOW The Future of Health Policy in the G7/G20 and Other Political Venues 14:00 – 15:30

HOSTS

German Federal Ministry of Health (BMG)

World Health Organization (WHO)

Healthcare has developed into a key strongly at the 2019 UNGA—it is also policy issue that is discussed at both part of the BRICS deliberations. There is national and international levels. In 2019, also an opportunity to give health a higher the G20 in Osaka, Japan, will include a profile in upcoming EU presidencies. meeting of health ministers in a forum set to cover topics like health security and This complementarity of agendas can antimicrobial resistance as well as a joint support the SDG approach to address meeting of finance and health ministers. current and future social, economic and The health governance issues inherent in environmental challenges through an the Sustainable Development Goals have integrated approach. The social, eco- underlined how increasing financial and nomic and environmental factors play political commitments—at global and an undeniable role in human health; at domestic level—are central to solving only through integration of the three global health challenges which must be dimensions will it be possible to achieve dealt with at the highest political level. the transformative change required The G7 will focus on issues of inequality to secure long-term environmental and including access to health. Health featured human well-being. PROGRAM 123

CHAIR

Ilona Kickbusch The Graduate Institute of International and Development Studies | Global Health Center | Chair of the International Advisory Board | Switzerland

Jens Jewel Spahn Howard Taylor SPEAKERS

Jens Spahn Jewel Howard Taylor Federal Minister of Health | Vice President | Liberia Germany Luiz Henrique Mandetta Tedros Adhanom Ghebreyesus Minister of Health | World Health Organization (WHO) | Brazil Director-General | Keizo Takemi Tedros Luiz Henrique United Nations Adhanom Mandetta Japan Center for International Exchange | Ghebreyesus Stefania Giannini WHO Goodwill Ambassador for UNESCO | UHC and Member of the House of Assistant Director-General for Education | Councillors Japan | France Japan

Stefania Keizo PROGRAM, TUE 29 Giannini Takemi

Ilona Kickbusch 124 TUESDAY, OCTOBER 29

PANEL DISCUSSION

PD 24 D I G I TAL H E A LTH Shaping Society and the Modern Economy SAAL 6 | EUROPE 14:00 – 15:30

HOST

Global He@lth 2030 Innovation Task Force

The pressures of growing youth and Following the first meeting of world ageing population will have a profound leaders on universal health coverage impact on global health spending, pre- (UHC) and launch of the Global Action dicted to rise to some $10 trillion in 2020. Plan for Healthy Lives and Well-Being New technological developments are for All at the UN General Assembly in responding by increasingly blurring the September 2019, as well as the antici boundaries between the physical, biologi- pated WHO Director General’s “Global cal, and digital worlds. Technology aims Strategy on Digital Health” in May 2020, to personalize precision medicine in order the stakes for advancing a truly global to tailor prevention and treatment to market in digital health for next genera- individual patients based on their genetic tion UHC and the SDGs by 2030 have makeup. This revolution can lead to taken on a new dimension. The next radically reduced costs and benefit the step is ensuring a transformative and health of all while increase patient em- multi-stakeholder ecosystem for the powerment but may result in new ethical sustainability of innovations and growth challenges and health inequities. of digital public goods, their economic viability, scale-up and inclusivity. PROGRAM 125

CHAIR

Denis Gilhooly Global He@lth 2030 Innovation Task Force | CEO | United States of America

SPEAKERS Peter Bernard Albiez Hamelin Peter Albiez Bernard Hamelin Pfizer Germany GmbH | Sanofi | Global Head of Medical Chief Executive Officer | Evidence Generation | Germany France

Francesca Colombo Marie-Josée Hébert Organization for Economic Cooperation Université de Montréal | and Development (OECD) | Vice-Rector of Research, Discovery, Francesca Marie-Josée Head of the Health Division | Creation and Innovation | Colombo Hébert France Canada

Diane Gashumba Soumya Swaminathan Minister of Health | World Health Organization (WHO) | Rwanda Chief Scientist | India

Diane Soumya

Gashumba Swaminathan PROGRAM, TUE 29

Denis Gilhooly 126 TUESDAY, OCTOBER 29

KEYNOTE

KEY 05 THE SDG3 GLOBAL ACTION PLAN SAAL 1 FOR HEALTH AND WELLBEING RUDOLF VIRCHOW 16:00 – 17:30

HOSTS

German Federal Ministry of Health (BMG)

World Health Organization (WHO)

The ultimate success of the SDGs will ment cooperation at country level as be measured by their impact on the well as enhanced stakeholder engage- prosperity and well-being of people and ment across sectors—at global, regional, the planet, particularly the extent to national and sub-national levels. which the SDGs “leave no one behind.” Initiatives such as the SDG3 Global Action The Action Plan was launched at the Plan for Health and Well-Being endeavor World Health Summit 2018—the actors to build a foundation of greater cohesion involved in the action plan will report among global health actors in support on its progress and the implementation of countries’ achievement of the health- challenges at hand. They will focus in related SDGs. But accelerating the pace particular on the seven accelerators of progress will require increased govern- that have been identified. PROGRAM 127

CHAIR

Ilona Kickbusch The Graduate Institute of International and Development Studies | Global Health Center | Chair of the International Advisory Board | Switzerland

Jane Ruth Magda Aceng Robalo Correia e Silva SPEAKERS

Jane Ruth Aceng Magda Robalo Correia e Silva Minister of Health | Minister of Public Health | Uganda Guinea-Bissau

Seth Berkley Peter Sands Gavi, The Vaccine Alliance | CEO | The Global Fund to Fight AIDS,

Jeremy Bernhard

Farrar Schwartländer PROGRAM, TUE 29

Ilona Kickbusch

GENERAL INFORMATION

GENERAL INFORMATION 130 USEFUL INFORMATION

ACCESS TO THE VENUE AND SECURITY EMERGENCY NUMBERS

Participants and speakers must present a valid photo ID Ambulance/Fire: 112 to pick up their badges. Please be advised that bags Police: 110 may be inspected for security reasons. We ask that you refrain from bringing luggage to the venue, as this INTERNET will slow down security procedures. Wifi is available throughout the venue. Badges should be worn at all times, and are required to enter all sessions and related events. Network: WorldHealthSummit Password: #WHS2019 CAPACITY LIMITS MEDIA Please note that the capacity of session rooms and the venue as a whole is limited. The organizers reserve The World Health Summit is fully open to the press. the right to refuse access if the maximum capacity Photography and filming are permitted. Journalists may has been reached. request press badges in advance online, or present a valid press ID at the venue entrance. Media information CLOAKROOM packets are available at the registration counter. A media center with workspace for journalists is available The cloakroom is located to the left of the entrance, on the upper level. and will be open for the duration of the event. LOST AND FOUND

Lost items can be collected at the registration counter during the World Health Summit. After the summit, unclaimed items will be held by the venue for a limited time only. USEFUL INFORMATION 131

PARKING SMOKING POLICY

Parking is available at the venue in an underground lot. Smoking is prohibited inside the venue.

PEOPLE WITH DISABILITIES SPEAKER CENTER

The venue is accessible to participants with disabilities. The speaker center is located on the upper level. If you require specific accommodations, please inform Speakers must bring any audio-visual materials they summit staff at [email protected] require to the speaker center prior to their session. Presentations cannot be run from personal laptops PROGRAM CHANGES in the session rooms. The speaker center is open during the following times: The program is subject to changes due to unforeseen Sunday, October 27 10:00 – 18:00 circumstances. Please check the interactive online Monday, October 28 8:00 – 18:00 program planner on our website for regular updates. Tuesday, October 29 8:00 – 17:00

REGISTRATION TAXIS

The registration desk is open during the following times: Taxi Berlin +49 30 202020 Sunday, October 27 8:00 – 23:00 Taxi Würfelfunk +49 30 210101 Monday, October 28 7:00 – 23:00 Taxi Funk +49 30 443322 Tuesday, October 29 7:00 – 18:00 132 USEFUL INFORMATION

CME CREDITS FOR PHYSICIANS

Continuing Medical Education and Professional Development

Berlin Chamber of Physicians – European Accreditation Council for Landesärztekammer Berlin Continuing Medical Education (UEMS/EACCME) Physicians attending the World Health Summit can The World Health Summit 2019, Berlin, Germany, receive six credits per day from the Berlin Chamber 27/10/2019-29/10/2019 has been accredited by the of Physicians. European Accreditation Council for Continuing Medical Education (EACCME®) with 16 European CME credits Each participant should claim only those hours of credit (ECMEC®s). Each medical specialist should claim only that he/she actually spent in the educational activity. those hours of credit that he/she actually spent in the educational activity.

Maximum Credits Maximum Credits

Sunday, October 27, 2019 6 Sunday, October 27, 2019 4 Monday, October 28, 2019 6 Monday, October 28, 2019 6 Tuesday, October 29, 2019 6 Tuesday, October 29, 2019 6

18 16

American Medical Association (AMA) Royal College of Physicians and Surgeons of Canada Through an agreement between the European Union Live educational activities, occurring outside of Canada, of Medical Specialists and the American Medical Asso- recognized by the UEMS-EACCME for ECMEC credits ciation, physicians may convert EACCME credits to an are deemed to be Accredited Group Learning Activities equivalent number of AMA PRA Category 1 Credits™. (Section 1) as defined by the Maintenance of Certifica- Information on the process to convert EACCME credit tion Program of The Royal College of Physicians and to AMA credit can be found at www.ama-assn.org/ Surgeons of Canada. education/cme/uemseaccme-cme-credit-recognition. 133 134 CITY OF BERLIN

BERLIN HEALTH EXCELLENCE – transfer the research results from the laboratory to EXPERTISE AND CUTTING-EDGE clinical care as quickly as possible and thus to provide patients in Berlin with the best possible care. This year MEDICINE MADE IN BERLIN Charité was ranked fifth best hospital worldwide by the US weekly Newsweek.

Other outstanding hospitals are the German Heart Berlin’s success as a health capital reflects a 300-year Centre (DHZB)—a top-level hospital for heart and tradition as a healthcare and scientific centre. More than vascular diseases under the leadership of world famous a dozen Nobel Prize winners worked here, including heart surgeon Professor Dr. med. Volkmar Falk—or researchers such as Rudolf Virchow and Robert Koch. Vivantes—with its nine clinics and several rehabilitation More than 90 hospitals with about 22,000 beds and centres being Germany’s largest hospital group. Many with 9,900 doctors on duty, respectively an additional more hospitals and doctor’s surgeries could be men- number of 9,200 doctors performing outpatient care tioned as all of them are offering top-class medical make Berlin one of the cities with the highest numbers treatment and provide medical experts of all disciplines. of doctors in Germany. Patients can thus find medical specialists for every disease. About 17,000 to 21,000 Medical care at the highest level requires a strong international patients are travelling to Berlin annually collaboration between scientists and practitioners. in order to undergo medical treatment. Berlin is a leading centre of science and research in Europe, especially focusing on medicine. Four universi- One of Berlin’s most famous medical institutions is the ties, the Charité teaching hospital, seven universities of renowned Charité, Europe’s largest university hospital applied sciences and over 30 private universities offer and one of Germany’s leading hospitals. World-renowned teaching and research facilities for people from all over scientists of the Charité cooperate closely with recog- the world. Germany’s most important research organi nised research organisations such as the Massachusetts zations such as the Fraunhofer-Gesellschaft or the Max Institute of Technology in Boston. Since 2019, the Berlin Planck Society are based in Berlin and successful tech- Institute of Health (BIH) has been integrated into the nology parks like the tech-hub Adlershof or biotech Charité, making research an important third pillar along- park Campus Berlin-Buch are established here. side health care and the medical faculty. The aim is to This environment also makes Berlin a popular destination for international congresses in science and medi- For more information about Berlin as a meeting cine: 22 per cent of the approximately 143,000 meet- destination, go to convention.visitBerlin.com. ings, conventions and events held in 2018 were in the fields of medicine, pharmaceuticals and health manage- Detailed information about diagnostics, ment. International conferences such as the World treatment and rehabilitation options in Berlin Health Summit show that the German capital has been can be found at berlin-health-excellence.com. able to consolidate its strong position as a destination for medical events. CITY OF BERLIN 135

BERLIN—CAPITAL OF CULTURE

Apart from the excellent quality of medicine, the capital For more information, of Germany with its green character, several parks and go to visitBerlin.com leisure facilities offers many ways to relax or support the patients’ recovery. Guests from abroad are increasingly investing in their health during their stay. It is only in Berlin that visitors can so perfectly combine health Berlin is the world’s only city to have three opera houses: consciousness, culture and lifestyle. the Berliner Staatsoper, the Deutsche Oper and the Komische Oper. Classical music lovers can choose from Cultural experiences in Berlin are of great variety. a repertoire of famous works, such as Mozart’s Don From ancient art by the Old Masters to avant-garde Giovanni, or new and experimental operas. Apart from design, from classical opera to musicals to pop con- these opera houses, the city’s eight large orchestras, certs, Berlin’s cultural calendar leaves nothing to be including the world famous Berlin Philharmonic con- desired. For all seasons, at all hours and for every ducted by Kirill Petrenko, also make for high-class taste, Berlin has something to offer. musical enjoyment. Culture and art enthusiasts can also admire new styles This year Berlin will be celebrating a special event. and prominent works from all eras every day in Berlin’s The November 9 marks the 30th anniversary of the fall over 180 museums and approximately 440 galleries. of the Berlin Wall. In the anniversary week from 4 to 10 The city’s best known museums include the five build- November, Berlin will become a huge open-air area ings at Museumsinsel, which is in the historic centre. for exhibitions, film screenings and concerts. visitBerlin All buildings display valuable artistic treasures from participates in the festivities with a unique art project: 3,000 years of human history, e.g. the famous bust of “Berlin Handshape”. Since 9 November 1989, 10,957 Nefertiti in the Neues Museum, while the Martin-Gropius- days will have passed since the fall of the Berlin Wall. Bau presents contemporary art. For every day without the border in the heart of the city, visitBerlin collects “Berlin Handshapes”, the hand- prints of two people. From Tuesdays to Sundays in the visitor centre at the Berlin Wall Memorial, people from different backgrounds can talk to each other and get involved in each other’s history. A piece of clay, held by both together and shaped by their handshake, symbol- izes the moment of their exchange and remains as a witness to their encounter. 136 WORLD HEALTH SUMMIT PRESIDENTS

PRESIDENTS 2019 FORMER PRESIDENTS

ALI JAFARIAN 2018 2018 2017 2016 Former Chancellor JOÃO GABRIEL SILVA FERNANDO REGATEIRO HÉLÈNE BOISJOLY ANTOINE FLAHAULT Tehran University Former Rector Chairman of the Board Dean Director of Medical Sciences University of Coimbra of Directors Faculty of Medicine, Institute of Global Health, Iran Portugal Coimbra University University of Montreal, University of Geneva, Hospitals, Portugal Canada Switzerland

DETLEV GANTEN 2015 2014 2013 2012 Founding President SHUNICHI FUKUHARA JOSÉ OTÁVIO AULER JR. JOHN EU-LI WONG MICHAEL J. KLAG World Health Summit, Former Dean Former Director Chief Executive Officer Former Dean Charité – Universitäts School of Public Health, Faculty of Medicine, National University Johns Hopkins Bloomberg medizin Berlin Kyoto University, University of São Paulo, Health System, School of Public Health, Germany Japan Brazil Singapore USA

2011 2010 2009 STEVE WESSELINGH STEVEN K. SMITH AXEL KAHN Dean Pro Rector, Health Dean Monash University, Imperial College London, Sorbonne Paris Cité, Melbourne, United Kingdom France Australia WORLD HEALTH SUMMIT 137 SCIENTIFIC COMMITTEE

CO-CHAIRS MEMBERS

STEFAN KAUFMANN FERNANDO REGATEIRO TILL BÄRNIGHAUSEN ELIZABETH BLACKBURN THOMAS B. CUENI Director Chairman of the Board Director Nobel Prize Laureate Director General Max Planck Institute of Directors Heidelberg Institute President Emerita International Federation for Infection Biology, Coimbra University Hospitals, of Public Health, Salk Institute of Pharmaceutical Manu Germany Portugal Germany for Biological Studies, facturers & Associations USA Switzerland The World Health Summit Scientific Committee consists of the M8 Alliance Executive Committee (see page 140) and selected members of the World Health Summit Council.

CHRISTIAN DROSTEN BÄRBEL-MARIA KURTH THOMAS METTENLEITER Director Director President Institute of Virology, Epidemiology and Institute of Molecular Charité – Universitäts- Health Monitoring, Virology and Cell Biology, medizin Berlin, Robert Koch Institute, Friedrich-Loeffler-Institut, Germany Germany Germany

MAIKE SANDER GÜNTER STOCK Director President Pediatric Diabetes ALLEA Research Center, All European Academies, UC San Diego, Germany USA 138 WORLD HEALTH SUMMIT AMBASSADORS AND COUNCIL

WORLD HEALTH SUMMIT AMBASSADORS COUNCIL

CHAIR

EDELGARD BULMAHN MANFRED DIETEL ECKART VON Former Federal Minister Former Director HIRSCHHAUSEN of Education and Research Institute of Pathology, Physician and Germany Charité – Universitäts Scientist for Future ILONA KICKBUSCH medizin Berlin, Germany Germany The Graduate Institute of International and Development Studies, Switzerland

MICHAEL RABBOW HEINZ RIEDERER REINHARD SCHÄFERS Senior Advisor Managing Director Former Ambassador E&P Focus Africa iNG innovation. Federal Republic Consulting, Nachhaltigkeit. of Germany Germany Gesundheit, Germany

ANSGAR TIETMEYER CHARLES YANKAH Member of the Chairman of the Board Board of Directors Afrika Kulturinstitut e. V., Maleki Corporate Group, Berlin, Germany Germany WORLD HEALTH SUMMIT COUNCIL 139

MEMBERS

ALA ALWAN THOMAS B. CUENI SUSANNA KRÜGER PETER PIOT University of Washington, Int. Federation of Save the Children London School of Hygiene Department of Global Health Pharmaceutical Manufacturers & Germany and Tropical Medicine Associations RIFAT ATUN BÄRBEL KURTH ERICH REINHARDT Harvard T.H. Chan School MANFRED DIETEL Robert Koch Institute Medical Valley of Public Health Charité – Universitäts- medizin Berlin STEVE LANDRY HEINZ RIEDERER TILL BÄRNIGHAUSEN Bill & Melinda Gates iNG innovation. Heidelberg University KLAUS DUGI Foundation Nachhaltigkeit. Gesundheit, Ferring Pharmaceuticals HANS-PETER BAUR YVES LEVY MAIKE RÖTTGER German Federal Ministry TIMOTHY EVANS Institut national de la santé Association Development for Economic Cooperation World Bank et de la recherche médicale and Humanitarian Aid and Development ROLAND GÖHDE MARION LIESER MATHIAS SCHELLER INGO BEHNEL German Health Alliance Oxfam Germany Albertinen-Diakoniewerk German Federal Ministry of Health JÖRG HACKER KLAUS LINDPAINTNER HANS J. SCHELLNHUBER German National Academy King Abdullah International Potsdam Institute for CHRISTOPH BEIER of Sciences Leopoldina e.V. Medical Research Center Climate Impact Research Deutsche Gesellschaft für Internationale SHANNON HADER PHILIPPE MEYER GEORG SCHÜTTE Zusammenarbeit UNAIDS Descartes University Incoming Secretary-General Volkswagen Foundation CHRISTOPH BENN ANDREW HAINES JÜRGEN MLYNEK Joep Lange Institute London School of Hygiene & Falling Walls Foundation GÜNTER STOCK Tropical Medicine European Federation TOBIAS BERGNER MATSHIDISO REBECCA MOETI of Academics of Sciences German Federal Foreign Office ZSUZSANNA JAKAB World Health Organization and Humanities World Health Organization ARNAUD BERNAERT BERND MONTAG LOTHAR WIELER World Economic Forum ASHISH JHA Siemens Healthineers Robert Koch Institute Harvard Global Health CATHERINA BÖHME Institute ANDREAS PENK Foundation for Innovative Pfizer Germany New Diagnostics STEFAN KAUFMANN Max Planck Institute HAGEN PFUNDNER for Infection Biology Roche Pharma AG 140 M8 ALLIANCE LEADERSHIP

EXECUTIVE COMMITTEE

ALI JAFARIAN DETLEV GANTEN CHARLES IBINGIRA AXEL RADLACH PRIES International President 2019 Founding President International President 2020 Dean of Host Institution Former Chancellor World Health Summit, Principal Charité – Universitäts- Tehran University of Charité – Universitäts- Makerere University medizin Berlin, Medical Sciences, medizin Berlin, College of Health Sciences, Germany Iran Germany Uganda

MICHAEL J. KLAG BEN CANNY DUARTE NUNO VIEIRA TARCÍSIO ELOY PESSOA Former Dean Former Head Dean DE BARROS FILHO Johns Hopkins Bloomberg School of Medicine, Faculty of Medicine, Dean School of Public Health, University of Tasmania, University of Coimbra Faculty of Medicine, Baltimore, Australia Portugal University of Sao Paulo, USA Brazil M8 ALLIANCE LEADERSHIP 141

M8 ALLIANCE HEADS OF DELEGATION

Australia France Italy

CHRISTINA MITCHELL GÉRARD FRIEDLANDER EUGENIO GAUDIO Dean Dean Rector Monash University Faculty of Medicine, University Sapienza University of Paris Descartes LUCIANO SASO Brazil FRANÇOIS HOULLIER Vice-Rector for European Acting President University Networks TARCÍSIO ELOY PESSOA Université Sorbonne Paris Cité Sapienza University DE BARROS FILHO Dean Faculty of Medicine, University of Sao Paulo Germany Japan

EDUARDO KRIEGER HEYO KROEMER SHUNICHI FUKUHARA Former President Chief Executive Officer Former Dean Brazilian Academy of Sciences Charité – Universitätsmedizin Berlin School of Public Health, Kyoto University

AXEL RADLACH PRIES Canada Dean Portugal Charité – Universitätsmedizin Berlin HÉLÈNE BOISJOLY AMÍLCAR FALCÃO Dean Rector Faculty of Medicine, University of Montreal Iran University of Coimbra

MAX FEHLMANN ALI JAFARIAN DUARTE NUNO VIEIRA President and Scientific Director Former Chancellor Dean Montreal Clinical Research Institute Tehran University of Medical Sciences Faculty of Medicine, University of Coimbra

AMIRHOSSEIN TAKIAN China Chair and Professor Russian Federation Global Health and Public Policy, XUETAO CAO Ministry of Health and Medical Education IVAN DEDOV President President Chinese Academy of Medical Sciences & Russian Academy of Medical Sciences Peking Union Medical College EVGENY SIDORENKO DEPEI LIU Vice-President Co-Chair Russian Academy of Medical Sciences InterAcademy Partnership (IAP) 142 M8 ALLIANCE LEADERSHIP

Singapore Taiwan USA

JOHN EU-LI WONG CHANG-CHUAN CHAN MICHAEL J. KLAG Chief Executive Officer Associate Dean Former Dean National University Health System National Taiwan University Johns Hopkins Bloomberg Senior Vice-President (Health Affairs), School of Public Health, Baltimore National University of Singapore Turkey ELLEN MACKENZIE KHAY GUAN YEOH Dean Dean MAHMUT AK Johns Hopkins Bloomberg Yong Loo Lin School of Medicine, Rector School of Public Health, Baltimore National University of Singapore Istanbul University

TEO YIK YING BAHAÜDDIN ÇOLAKOGLU International Vice-Dean (Research) Dean Saw Swee Hock School of Public Health Istanbul University, Faculty of Medicine STEVEN L. KANTER National University of Singapore President & CEO Association of Academic Health Centers Uganda (AAHC) Switzerland CHARLES IBINGIRA LEONEL VALDIVIA ANTOINE FLAHAULT Principal President Director Makerere University World Federation of Academic Institute of Global Health, College of Health Sciences Institutions for Global Health (WFAIGH) University of Geneva

CEM GABAY United Kingdom Individual Member Dean Faculty of Medicine, University of Geneva PETER PIOT RIFAT ATUN Director Director BERTRAND LEVRAT London School of Hygiene & Global Health Systems Cluster, Chief Executive Officer Tropical Medicine Harvard T.H. Chan School of Public Health, Geneva University Hospitals USA ELIO RIBOLI VINH-KIM NGUYEN Director Director School of Public Health, Global Health Center, Graduate Institute Imperial College London

NICOLE ROSSET Deputy Director Geneva University Hospitals (HUG), External Affairs and Executive Management Member SPEAKER INDEX 143

A Aceng, Jane Ruth 69, 79, 89, 127 Bhola, Mukul 115 De Negri, Alberto 31 Germann, Stefan 81, 113 Achimas-Cadariu, Patriciu 39 Bloch, Gilles 31 Devoy, Michael 107 Gerritsen, Don 99 Adams, Cary 87 Bocchi, Massimo 75 Dhatt, Roopa 23 Ghaffar, Abdul 89 Adeoye, Olawunmi 85 Boehme, Catharina 87 Diment, Judith 25 Giannini, Stefania 123 Adhanom Ghebreyesus, Boisjoly, Hélène 23 Donnelly, Alan 35 Gilhooly, Denis 125 Tedros 123 Bolton, Samantha 71 Draghia, Ruxandra 69 Gitahi, Githinji 57 Aerts, Ann 91 Bork, Peer 51 Goffinet, Christine 35 Agogo, Emmanuel 111 Botha, Theuns 83 E Göhde, Roland 45, 91 Agrawal, Anurag 113 Boufford, Jo Ivey 119 Elhadidy, Mohamed 121 Gorgens, Marelize 113 Agyeman-Manu, Kwaku 73, 79 Brand, Helmut 83 Elinav, Eran 51 Grasselli, Nora Ilona 119 Ahrens, Wolfgang 29 Britnell, Mark 67 Elphick-Pooley, Thoko 87 Grützmacher, Kim 77 Akuffo, Hannah 93 Bucher, Anne 31, 43 ElZarrad, Khair 81 Guevara, Maria S. 39 Albiez, Peter 125 Bulmahn, Edelgard 47 End Fineberg, Alison 89 Amuasi, John 73, 77 Busse, Reinhard 89 Erondu, Ngozi 111 H Antony, Sahayarani 63 Etienne, Carissa F. 57 Hachmann, Janna 75 Aruna, Olúṣọlá 85 C Hagen, Hans 93 Awan, Almas Taj 121 Campbell, Jim 67 F Haines, Andrew 65, 101 Azadzoy, Hila 33 Carabin, Hélène 73 Falkenberg, Timo 77 Hajjeh, Rana A. 47 Carlsson, Gunilla 35, 45 Farrar, Jeremy 127 Hall, Julie Lyn 67 B Catena, Tom 67 Farrukh, Muhammad Hamelin, Bernard 125 Balasegaram, Manica 61, 87 Cediel Becerra, Natalia Akhyar 121 Hamer, Berit 89 Baptista Leite, Ricardo 35 Margarita 85 Fears, Robin 101 Harris, Alex 117 Bärnighausen, Till 91 Chalkidou, Kalipso 95 Flachsbarth, Maria 79, 103, 115 Harrison, Wendy 73 Barquera, Simon 41 Chan, Margaret 57 Flahault, Antoine 37 Hazelzet, Jan 105 Barr, Epsy Campbell 23 Chataway, Mark 43, 117 Flora, Meerjady Sabrina 111 Hazen, Stanley 51 Bates, Imelda 93 Chinyenze, Kundai 93 Forslund, Sofia 51 Hébert, Marie-Josée 125 Baumann, Susanne 69 Colombo, Francesca 95, 125 Forster, Alexandra 49 Hebestreit, Antje 29 Beck, Jan-Philipp 33 Cueni, Thomas 61, 79 Foster, Juliette 115 Heide, Lutz 49 Benn, Christoph 91 Foulkes, Imogen 61 Herfurth, Tanya 45 Benzler, Justus 85 D Hirsch, Martin 39 Berkley, Seth 127 Dabrock, Peter 33 G Hochfeld, Christian 65 Bernhardt, Martin 87 Danquah, Ina 29 Gabrysch, Sabine 65 Hofstraat, Hans 33 Beyer, Peter 27, 49, 61 de-Graft Aikins, Ama 41 Ganten, Detlev 52 Holtherm, Hans-Ulrich 69 Bhardwaj, Harsh 83 Dehmel, Susanne 33 Gashumba, Diane 115, 125 Hörauf, Achim 63 144 SPEAKER INDEX

Htwe, Myint 115 Kühnert, Denise 39 Messner, Angelika 41 Oni, Tolullah 47, 53 Hyder, Adnan A. 89 Kuykens, Luc 71 Miah, Ronald 29 Orcutt, Miriam 37 Moges, Beyene 111 I L Montag, Bernd 53, 81 P Ibingira, Charles 53, 79 Lasry, Estrella 71 Monti, Roberto Francesco 47 Palu, Toomas 117 Ioannidis, John P.A. 31 Lechler, Sir Robert 105 Moriarty, Glen 59 Passaris, Esther 35 Iyer, Jayasree K. 79 Lee, Naomi 81 Mori, Chisato 65 Patel, Vikram 59 Lejon, Veerle 71 Morozov, Alexey 83 Peeters, Jaak 35 J Levin, Maria 75 Mpundu, Mirfin 49, 61 Perry, Greg 87 Jafarian, Ali 47, 53 Levy, Mayaan 51 Mwamba Miaka, Erick 71 Piyawattanametha, Jahrmann Bjerke, Maria 73 Liu, Depei 41 Mwasuka, Grace 63 Wibool 121 Jianrong, Qiao 83 Loew, David 43, 53 Pries, Axel 31 Loyse, Angela 109 N Pshenichnaya, Natalia 91 K Luft, Christian 53 Napier, David 41 Kapina, Mazala 85 Luz Lima, Maria 85 Natterson-Horowitz, R Karabey, Selma 37 Barbara 39, 77 Ratsiambakaina, Diana 91 Karsten, Maria Margarete 105 M Neira, Maria 65 Refsum, Charlotte 23 Kasonde, Mwenya 23 Madhavan, Guru 121 Nesse, Randolph 39 Riedl, Felicitas 27 Kassim, Mansura M. 29 Maher, Dermot 93 Nicknam, Mohammad Robalo, Magda 127 Kaufmann, Stefan 109 Makanga, Michael 107, 109 Hossein 47 Rosshart, Stephan Patrick 51 Kehoe, Sean 103 Malecela, Mwelecele Nilsson, Maria 101 Rossouw, Hélène 83 Kelly-Hope, Louise 63 Ntuli 63, 71 Nimmesgern, Elmar 27 Ruffolo, Antonio 115 Kestel, Devora 59, 115 Mandetta, Luiz Henrique 123 Nishtar, Sania 53 Rühli, Frank 39 Kickbusch, Ilona 25,57, 123, 127 Markels, John 117 Njenga, Eva 87 Ryan, Michael 69, 85 King, Bronwyn 99 Masala, Carlo 69 Nsiah Asare, Anthony 73 Klapper, Bernadette 95 Matijasevich Manitto, Alicia 83 Nsubuga, Peter 85 S Klumpers, Johannes 101 Matlin, Stephen 25 Nusser, Harald 57 Sambuli, Nanjira 113 Köhler, Carsten 63 Mattar, Caline 23 Sancho Mas, Javier 107 Kohler, Stefan 121 May, Jürgen 77 O Sands, Peter 109, 127 Kornely, Frank 103 Mazzoleni Insfrán, Julio Oberreiter, Michael 45 Santuccione Chadha, Krause, Gérard 85 Daniel 43, 95 Ochu, Chinwe Lucia 117 Antonella 59 Krech, Rüdiger 111 Mburu, Rosemary 117 Ohura, Catherine K. 109 Saso, Luciano 37 Kristensen, Frederik 57 McGrath, Peter 119 Okereke, Ebere 111 Saunders, Mark 99 Kroemer, Heyo 53, 105 Mehta, Sonal 45 Olesen, Ole 93 Schäfers, Reinhard 41 SPEAKER INDEX 145

Schöwel, Verena 75 T Wickramasinghe, Kremlin 29 Schrade, Christina 23 Tadesse, Lia 45 Wiegand, Thomas 81, 113 Schwartländer, Takemi, Keizo 123 Wieler, Lothar H. 27, 43, 73, 111 Bernhard 25, 73, 127 Takian, Amirhossein 37 Winkler, Andrea 73, 77 Schwendicke, Falk 75 Talisuna, Ambrose Otau 85 Wiskow, Christiane 23 Segre, Julie 51 Tanner, Marcel 93 Wolpert, Miranda 59 Sehouli, Jalid 103 Tatay, Mercedes 69 Wong, John Eu-Li 67 Seth, Nikhil 115 Taylor, Jewel Howard 123 Wulf, Andrea 53 Severoni, Santino 37 Tedla, Shushan 49 Sevilla, JP 43 Teguete, Ibrahima 103 Z Seybold, Joachim 37 ter Meulen, Volker 101 Zandvliet, Ruben 99 Shaikh, Mujaheed 95 Thompson, Kirsty 63 Zinsstag-Klopfenstein, Jakob 77 Shalini Subash, Arya 121 Timmers, Paul 33 Siegmund, Britta 31 Trattler, Daniel 75 Sillanaukee, Päivi 31 Simão, Leonardo 93 U Simelela, Princess Ullrich, Andreas 103 Nothemba 103 Sipido, Karin R. 31 V Snower, Dennis J. 57 Velasco Muñoz, César 105 Sodahlon, Yao 63 Vermeir, Koen 121 Sosler, Stephen 25 Viola, Roberto 33 Spahn, Jens 53, 123 von Hirschhausen, Eckart 65 Spencer, Julia 27 von Kalle, Christof 81 Stoltenberg, Camilla 73 von Messling, Veronika 109 Strub-Wourgaft, Nathalie 71, 107 W Sukhdev, Pavan 99 Waldstreicher, Joanne 113 Sunkel, Charlene 59 Wallensten, Anders 85 Suprun, Ulana 99 Walzer, Chris 77 Su, Yi-Chang 41 Walzl, Gerhard 109 Swaminathan, Wasunna, Monique 107 Soumya 43, 81, 109, 125 Welch, Darren 25 Sy, Elhadj As 111 Wendt, Claus 95 146 SUPPORTING INSTITUTIONS

A G Association of Research-based Pharmaceutical German Federal Foreign Office 68 Companies (vfa) 48, 62 German Federal Ministry of Defense 68 ATscale – Global Partnership for Assistive Technology 88 German Federal Ministry of Education and Research (BMBF) 72, 92 B German Federal Ministry of Health (BMG) 122, 126 Berlin Institute of Health (BIH) 80 German Health Alliance (GHA) 44 BioMed Alliance 30 German Institute of Human Nutrition Potsdam-Rehbrücke Boehringer Ingelheim Pharma GmbH & Co.KG 114 (DIfE) 28 German National Academy of Sciences Leopoldina e.V. 100 C German Network against Neglected Tropical Diseases Centre on Global Health Security 110 (DNTDs) 62 Charité – Universitätsmedizin Berlin 30, 64, 102, 108 German Society for Tropical Medicine and International Charité Global Health 90 Health (DTG) 62 Global Antibiotic Research & Development Partnership D (GARDP) 60 Drugs for Neglected Diseases initiative (DNDi) 70, 106 Global He@lth 2030 Innovation Task Force 124 Global Solutions Initiative 56 E Global Young Academy 120 Eberhard-Karls-University Tuebingen 62 EIT Health (European Institute for Innovation and H Technology) 32 Harvard Medical School 58 ESMT European School of Management and Technology Heidelberg Institute of Global Health (HIGH) 90 GmbH 118 Helmholtz Centre for Infection Research (HZI) 84 European & Developing Countries Clinical Trials Partnership Hertie School 94 (EDCTP) 92, 108 European University Hospital Alliance 104 I Institut Pasteur 92 F InterAcademy Partnership (IAP) 46, 100, 118 Fondation Botnar 112 International Association of National Public Health Fraunhofer Heinrich-Hertz-Institut 80 Institutes (IANPHI) 110 International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) 86 Istanbul University 36 SUPPORTING INSTITUTIONS 147

K T Kiel University 40 Tehran University of Medical Sciences (TUMS) 36, 46 The Defeat-NCD Partnership 114 L The George Washington University, Lancet Commission on One Health 72, 76 Milken Institute School of Public Health 88 Leibniz Institute for Prevention Research and Epidemiology The Graduate Institute Geneva – Global Health Center 24, 56 (BIPS) Bremen 28 The Lancet & Financial Times Commission 112 Tobacco Free Portfolios 98 M M8 Alliance 24, 30, 36, 40, 46, 52, 56, 64, 66, 78, 102, 108 U Makerere University 78 UHC2030 56 Manipal Academy of Higher Education 82 UNAIDS 44 Max Delbrück Center for Molecular Medicine (MDC) 50 UNITE 34 Max Planck Institute for Infection Biology 108 Universitätsklinikum Tuebingen 62 University of Geneva 36 N University of Zurich 38 National University of Singapore (NUS) 66 W O Wellcome Trust 116 Ottobock SE & CoKgaA 88 Women in Global Health 22 World Health Organization (WHO) 26, 122, 126 P World Health Summit 52, 120 Potsdam Institute for Climate Impact Research 64

R Robert Bosch Stiftung 94 Robert Koch Institute 110

S Sanofi 42, 70 Sapienza University 36 Stiftung Mercator 64 148 PARTNERS

SPONSORING PARTNERS

Strategic Partners

Major Partners Gerneral Partners PARTNERS 149

SUPPORTING PARTNERS

SERVICE PARTNERS 150 PARTNERS

POLICY MAKERS

Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH

ACADEMIA

PARTNERS 151

CIVIL SOCIETY

H E E M C O LU R SCHOOL B OF 152 PARTNERS

ASSOCIATES

Digital Health

MEDIA PARTNERS

In Zusammenarbeit mit: Polish Healthcare Journal

Ogólnopolski System Ochrony Zdrowia WORLD HEALTH SUMMIT OFFICE 153

President Director of Operations Detlev Ganten Petra Neitzel [email protected] [email protected]

Managing Director Press and Public Relations Officer Jörg Heldmann Katherine Lindemann [email protected] [email protected]

Program Director Strategic Partnerships Officer Julian Kickbusch Lukas Pfannenschmidt [email protected] [email protected]

Strategic Communications Director PA to the President Daniela Levy Pascale Schulte [email protected] [email protected]

Director of Office Manager International Cooperations Martin Liedtke Nora Anton [email protected] [email protected]

The World Health Summit is organized in cooperation with: With support from: 154 NOTES NOTES 155 156 IMPRINT

Photo Credits

Angela Merkel, Page 6 © Bundesregierung / S. Kugler Christiane Wiskow, Page 23 © Studioregard Christina Schrade, Page 23 © Stefan Wieland Anne Bucher, Page 31, 43 © European Union Britta Siegmund, Page 31 © Wiebke Peitz Susanne Dehmel, Page 33 © Till Budde Jaak Peeters, Page 35 © Steffen Hoeft – Düsseldorf Christine Goffinet, Page 35 © 2018 Thomas Rafalzyk Luciano Saso, Page 37 © stephenbusuttil.com Randolph Nesse, Page 39 © Arizona Board of Regents David Loew, Page 43, 53 © Céline Clanet – Interlinks Image Edelgard Bulmahn, Page 47, 138 © Deutscher Bundestag Sofia Forslund, Page 51 © Pagblo Castagnola Miranda Wolpert, Page 59 © Wellcome Carsten Köhler, Page 63 © UKT Kirsty Thompson, Page 63 © Divya Paul Eckart von Hirschhausen, Page 65, 138 © Camillo Wiz Nathalie Strub-Wourgaft, Page 71, 107 © Laurent Egli Luc Kuykens, Page 71 © Vincent MONCORGE Camilla Stoltenberg, Page 73 © Marius Tharaldsen Verena Schöwel, Page 75 © Bernd Jaworek Jayasree K. Iyer, Page 79 © www.patriciawolf.nl Maria Flachsbarth, Page 79, 103, 115 © Thomas Trutschel-photothek.net Layout Thomas Wiegand, Page 81, 113 © Die Hoffotografen GmbH Berlin Eta Friedrich, Berlin Anders Wallensten, Page 85 © Lena Katarina Johansson Hans Hagen, Page 93, © Institut Pasteur, François Gardy Printer Mujaheed Shaikh, Page 95, © Vincent Mosch Spree Druck, Berlin Kalipso Chalkidou, Page 95 © Robin Stanley Bernadette Klapper, Page 95 © Michael Fuchs Mark Saunders, Page 99 © Alphaville Limited Johannes Klumpers, Page 101 © Benedicte Maindiaux Maria Nilsson, Page 101 © Ulrika Bergfors Kriström Jalid Sehouli, Page 103 © Wiebke Peitz Michael Devoy, Page 107 © Matti Hillig Myint Htwe, Page 115 © Phyo WP (CC BY-SA 4.0) John Markels, Page 117 © Merck & Co., Inc. Bärbel-Maria Kurth, Page 137 © Robert Koch-Institut / Dugnus Charité – Universitätsklinik, Page 134 © Charité Gendarmenmarkt, Page 135 © Gutscherra / Osthoff World Health Summit

WHS Foundation GmbH c / o Charité – Universitätsmedizin Berlin Charitéplatz 1 10117 Berlin Germany

Tel.: +49 30 450 572102 Fax: +49 30 450 572911

[email protected] www.worldhealthsummit.org SAVE THE DATES

WORLD HEALTH SUMMIT REGIONAL MEETING AFRICA

KAMPALA, UGANDA APRIL 27–28, 2020

WORLD HEALTH SUMMIT

BERLIN, GERMANY OCTOBER 25–27, 2020